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ABSTRACT 
 
 Down Syndrome (DS) is the most frequent autosomal aneuploidy 
compatible with post-natal life. It has been attributed to the overexpression of 
chromosome 21 (Hsa21) genes. At least 80 phenotypic signs such as mental 
retardation, cardiac defects, muscle hypotonia, immunological disorders have 
been described in DS, however, it is unknown which, and how many, Hsa21 
genes are responsible for each sign.  
Hsa21 trisomy has been associated to mitochondrial dysfunction in different 
tissues and a global downregulation of nuclear genes encoding mitochondrial 
enzymes (NEMG) has been demonstrated in heart tissues from DS suggesting 
that the dysfunction may contribute to the DS phenotype.  
To establish which correlation there might be between NEMG regulation and 
mitochondrial function in DS, we undertook molecular, functional and 
morphological studies on mitochondria in primary lines of fetal fibroblasts 
(DS-HFF). Hsa21 genes were globally upregulated and NEMGs were 
downregulated in DS-HFF, like in fetal hearts, and a mitochondrial dysfunction 
was observed.  
The aim of this work is to understand how alterations in the expression of 
specific Hsa21 genes might cause mitochondrial dysfunction.  
Based on literature and prediction databases, the nuclear receptor interacting 
protein RIP140 and the miRNA let-7c both mapping to Hsa21 were 
hypothesized to affect oxidative metabolism and mitochondria biogenesis in 
DS. RIP140 negatively controls the expression of the transcriptional 
coactivator PGC-1α, a key gene for mitochondrial biogenesis and NEMG 
expression, which was found downregulated in DS-HFF. To verify the 
hypothesis that RIP140 overexpression might cause PGC-1α downregulation, 
RIP140 silencing experiments were performed in DS-HFF demonstrating an 
inverse correlation between RIP140 and PGC-1α expression and a partial 
recovery of mitochondrial activity upon downregulation of RIP140 expression. 
The role of miRNA let-7c in mitochondrial dysfunction was also investigated. 
Let-7c is upregulated in DS fetal tissues and among its predicted it is included 
the adenine nucleotide translocator-1 (ANT1), a gene responsible for the 
ATP/ADP exchange through the mitochondrial inner membrane. We found that 
in vitro let-7c upregulation caused ANT1 downregulation, suggesting that the 
upregulation of let-7c, due to primary gene dosage effect, might contribute to 
the energy deprivation in mitochondrial dysfunction. 
These findings have potential therapeutic implications based either on in vivo 
inhibition of RIP140 gene or on the activation of key genes repressed by the 
overexpression of Hsa21 regulators. 
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INTRODUCTION 
 
Down Syndrome 
 
 Down Syndrome (DS), caused by a complete or partial trisomy of 
chromosome 21 (Hsa21), occurs with a frequency of 1/700 births. Its complex 
phenotype is characterized by about 80 features with various degrees of 
expression and frequency (Epstein et al. 1991). Constant features are mental 
retardation, hypotonia, developmental delay, a partial immune deficiency, and 
an increased risk of leukemia. DS is a major cause of congenital heart defects 
(CHD) associated mostly to endocardial cushion defects (Ferencz et al. 1989, 
Park et al. 1977), mainly atrioventricular canal defects (AVCD) followed by 
ventricular septal defects (VSD) and complex malformations such as tetralogy 
of Fallot (TOF) (Park et al. 1977).  
The life expectancy of DS subjects is 45-50 years. Starting from the age of 40 
years old, DS subjects very commonly suffer from Alzheimer's disease (Cork 
1990), autoimmune diseases and thyroid dysfunction typical of older 
population. 
 
Gene expression in DS 
 
 It has been widely demonstrated that three copies of Hsa21 cause the 
overexpression of Hsa21 genes as a primary dosage effect. This produces, as 
secondary effect, the dysregulation of genes mapping to different chromosomes 
and as final effect the DS phenotype (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Primary and secondary effects of trisomy 21. Three copies of Hsa21 may 
cause a 50% increase in the expression of trisomic genes as primary dosage effect. The 
dysregulation of Hsa21 genes may cause alteration of disomic gene expression as 
secondary effects. Both primary and secondary effects will finally result in developmental 
defects and phenotypic alterations. 
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Several studies reported a global 1,5 fold overexpression of triplicated genes in 
mouse models of DS and in DS subjects (Kahlem et al. 2004; Lyle et al. 2004; 
Dauphinot et al. 2005). Interestingly, only a subset of chromosome 21 (Hsa21) 
genes is overexpressed in trisomic samples (FitzPatrick et al. 2002; Mao et al. 
2005, Conti et al. 2007). The increase in expression may slightly differ from 
the expected ~1.5-fold and the set of over-expressed Hsa21 genes differs across 
the trisomic cell types (Amano et al. 2004; Li et al. 2006) and developmental 
stages indicating that other factors might also affect gene expression (Sommer 
and Henrique-Silva 2008). 
In order to evaluate primary and secondary dosages gene effects in DS fetuses 
a gene expression profiling of fetal heart tissue by microarray technology has 
been performed (Conti et al. 2007). This study analyzed 15 fetal hearts at 18-22 
weeks of gestation divided into 3 groups: 5 DS with CHD, 5 without CHD and 
5 euploid fetuses. This analysis concerned 15.000 genes, including 168 Hsa21 
genes. Microarray data demonstrated that  Hsa21 genes were globally 
upregulated and that 441 genes, located on other chromosomes, were 
significantly dysregulated in trisomic heart samples. Downregulation of genes 
encoding mitochondrial enzymes (NEMG) and upregulation of genes encoding 
extracellular matrix (ECM) proteins appeared to be a hallmark of trisomy 21 in 
fetal heart samples: 65 out of 600 NEMG were downregulated and 40 out of 
700 ECM genes were upregulated (Table 1). Downregulated NEMG were 
involved in all the respiratory complexes. 
 
Table 1. List of genes encoding mitochondrial proteins downregulated in DS fetal 
hearts. 
 
Probe ID 
Fold Change 
Gene Name Genbank ID (DS/euploid ratio) 
214274_s_at 0.647 ACAA1 AI860341 
215210_s_at 0.548 ACADM S72422 
205412_at 0.756 ACAT1 NM_000019 
208967_s_at 0.757 AK2 U39945 
201322_at 0.739 ATP5B NM_001686 
208972_s_at 0.739 ATP5G1 AL080089 
211715_s_at 0.554 BDH1 BC005844 
205295_at 0.699 CKMT2 NM_001825 
209746_s_at 0.721 COQ7 AF032900 
203858_s_at 0.74 COX10 NM_001303 
218057_x_at 0.738 COX4NB BC001472 
201597_at 0.764 COX7A2 NM_001865 
201633_s_at 0.727 CYB5B AW235051 
208905_at 0.702 CYCS BC005299 
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209759_s_at 0.729 DCI BC002746 
211150_s_at 0.568 DLAT J03866 
204824_at 0.638 ENDOG NM_004435 
201931_at 0.698 ETFA NM_000126 
202942_at 0.692 ETFB NM_001985 
213133_s_at 0.713 GCSH AW237404 
221415_s_at 0.545 GJA10 NM_030772 
200947_s_at 0.758 GLUD1 NM_005271 
208813_at 0.671 GOT1 BC000498 
203745_at 0.678 HCCS AI801013 
200691_s_at 0.645 HSPA9B NM_004134 
210046_s_at 0.743 IDH2 U52144 
202070_s_at 0.709 IDH3A NM_005530 
210418_s_at 0.751 IDH3B AF023265 
200955_at 0.704 IMMT NM_006839 
36830_at 0.711 MIPEP U80034 
219527_at 0.701 MOSC2 NM_017898 
218027_at 0.716 MRPL15 NM_014175 
203781_at 0.741 MRPL33 NM_004891 
218890_x_at 0.745 MRPL35 NM_016622 
204331_s_at 0.735 MRPS12 AA587905 
220864_s_at 0.638 NDUFA13 NM_015965 
202077_at 0.748 NDUFAB1 NM_005003 
218201_at 0.669 NDUFB2 NM_004546 
201226_at 0.663 NDUFB8 NM_005004 
201966_at 0.62 NDUFS2 NM_004550 
201740_at 0.72 NDUFS3 NM_004551 
201757_at 0.763 NDUFS5 NM_004552 
202941_at 0.76 NDUFV2 NM_021074 
218455_at 0.712 NFS1 NM_021100 
202780_at 0.705 OXCT1 NM_000436 
200980_s_at 0.598 PDHA1 BF739979 
214225_at 0.677 PIN4 BE674061 
203649_s_at 0.657 PLA2G2A NM_000300 
205241_at 0.724 SCO2 NM_005138 
201093_x_at 0.591 SDHA NM_004168 
202675_at 0.744 SDHB NM_003000 
8 
 
202004_x_at 0.722 SDHC NM_003001 
203340_s_at 0.688 SLC25A12 AI887457 
217961_at 0.705 SLC25A38 NM_017875 
202825_at 0.607 SLC25A4 NM_001151 
216841_s_at 0.734 SOD2 X15132 
218119_at 0.634 TIMM23 NM_006327 
203092_at 0.612 TIMM44 AF026030 
220415_at 0.635 TNNI3K NM_015978 
209077_at 0.74 TXN2 AL022313 
201903_at 0.75 UQCRC1 NM_003365 
200883_at 0.716 UQCRC2 NM_003366 
208909_at 0.744 UQCRFS1 BC000649 
217140_s_at 0.637 VDAC1 AJ002428 
217249_x_at 0.68 WUGSC:H_RG162B04.1 AC004544 
 
 
Mitochondrial dysfunction in DS 
 
 Trisomy of chromosome 21 (TS21) has been associated to 
mitochondrial dysfunction, in several DS cells (Busciglio et al. 1995; Roat et 
al. 2007) and in mouse models (Shuchman et al. 2000; Shukkur et al. 2006), 
suggesting that a mitochondrial dysfunction might contribute to the DS 
phenotype. Data from functional studies suggest that Hsa21 trisomy affects 
mitochondrial function and reactive oxygen species production (Gardiner 
2003). DS has been associated to oxidative stress, increase of reactive oxygen 
species (ROS) formation, altered intracellular calcium homeostasis, increase of 
apoptosis, decrease of protein level of complexes I, III and V in cerebellar and 
brain regions (Bambrick et al. 2008). Complex I was also deficient in mouse 
models of trisomy of chromosome 16. Impaired mitochondrial function, 
indicated by reduced mitochondrial redox activity and membrane potential, has 
been observed in DS astrocytes and in primary cultures of DS fibroblasts 
(Arbuzova et al. 2002, Busciglio et al. 2002). Deregulation of Ca2+ homeostasis 
and Ca2+-mediated signaling has been described in cells derived from trisomic 
patients and in mouse models of DS (Caviedes et al. 2006; Yamato et al. 2009) 
since mitochondria function as a Ca2+  buffer.  It has also been reported that the 
brain of the DS mouse model Ts1Cje has decreased mitochondrial membrane 
potential and ATP production (Shukkur et al. 2006). Recently it has been also 
reported that fetal DS fibroblasts show a decreased efficiency of the 
mitochondrial energy production apparatus, selectively involving ANT 
(adenine nucleotide translocator), ATP synthase and AK (adenylate kinase) and 
a selective deficit of complex I, which contributes to ROS overproduction by 
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DS mitochondria possibly related to changes in the cAMP/PKA signaling 
pathway (Valenti et al. 2010; Valenti et al. 2011). 
Even though these results are indicative of widespread mitochondrial 
dysfunction in DS, molecular studies have not yet been performed to 
investigate the basis of mitochondrial dysfunction at the transcriptional level. 
Furthermore, no hypotheses have been formulated about the mechanisms by 
which trisomy of Hsa21 genes might induce such a dysfunction. 
DS mitochondrial dysfunction is similar to the dysfunction associated to 
models of Parkinson's disease. This evidence suggests that different 
neurodegenerative diseases may be associated with the same mitochondrial 
dysfunction (Bambrick et al. 2008). 
 
 
Transcriptional regulation of mithocondrial biogenesis, function and              
morphology 
 
 Mitochondria are cytoplasmatic organelles elongated in shape. They are 
present in all eukaryotic cells and can vary in size, indeed their average 
diameter is approximately 1µm.  The overall volume of mitochondria is high 
(from hundreds to thousands per cell) in tissues and organs with high metabolic 
activity such as brain, retina, skeletal muscle, heart, kidney, and endocrine 
glands. The shape and number of these organelles are regulated by fission and 
fusion processes which vary depending on the function of the cell and tissue. 
Mitochondria are surrounded by outer and inner membranes that are consistent 
with their symbiontic origin. The outer membrane is smooth and permeable, 
whereas the inner envelope is highly folded and structured in cristae and offers 
the major permeability barrier to ions and molecules that traverse to the inner 
mitochondrial compartment by active transport.  
The two envelopes enclose an intermembrane space and matrix, where the 
basic mitochondrial macromolecular syntheses (DNA replication, transcription, 
and translation) take place. 
The main function of the mitochondrion is the production of energy, in the 
form of adenosine triphosphate (ATP), by the oxidative phophorylation 
(OXPHOS) process (Figure 2).  
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Figure 2. The OXPHOS process. Schematic representation of the complexes activity 
during the OXPHOS. The transition of the electrons is accompanied by a translocation of 
protons across the mitochondrial membrane. This phenomenon produces a chemical 
gradient (Phi) and an electrical gradient (∆ψ). 
 
The OXPHOS system is embedded in the lipid bilayer of the mitochondrial 
inner membrane and is composed by five multiprotein enzyme complexes (I–
V) and two electron carriers – coenzyme Q and cytochrome c. During 
OXPHOS the charged molecules are processed within the five electron 
transport chain complexes to finally combine with oxygen to release the energy 
needed to make ATP. Complex I is called NADH ubiquinone oxidoreductase 
and it can be inhibited by rotenone; complex II is called succinate ubiquinone 
reductase and it can be inhibited by malate which competes with the substrate; 
complex II is called cytocrome bc1 or ubiquinone cytocrome c oxidoreductase 
and it can be inhibited by antimycin and/or myxothiazol; complex IV is called 
cytocrome oxidase and it can be inhibited by potassium cyanide (KCN); 
finally, there is the ATP synthase enzyme. Mitochondrial OXPHOS constitutes 
the major cellular ATP-producing mechanism under aerobic conditions. A 
consequence of mitochondrial activity is the production of ROS that refers to a 
group of oxygen containing compounds with the ability to react with reduced 
compounds. They comprise superoxide (O2--•), hydrogen peroxide (H2O2), and 
the highly reactive hydroxyl radical (•OH), although minor amounts of singlet 
oxygen can also be formed by cells. The initial product of the electron transport 
chain is O2--•, which is quickly transformed into H2O2 by the enzyme 
superoxide dismutase (SOD). H2O2 can be reduced to water by catalase or 
glutathione peroxidase or can be converted into •OH in presence of reduced 
transition metals (reduced copper or iron). 
The main source of O2--• are respiratory complexes I and III located at the inner 
mitochondrial membrane (Chen et al. 2003; Camello-Almaraz et al. 2006).  
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With only 13 OXPHOS polypeptides encoded by mitochondrial DNA 
(mtDNA) (Figure 3), most of the OXPHOS subunits (at least 70) are encoded 
by the nuclear genome.  
 
 
 
Figure 3. Human mitochondrial DNA (mtDNA).The genomic organization and structural 
features of human mtDNA in a circular double strand. 
 
The transcriptional regulatory network controlling the expression of nuclear 
and mitochondrial genes includes nuclear respiratory factors NRF-1 and NRF-
2 and mitochondrial transcription factor A (Tfam or mtTFA). NRF-1 
transcriptionally controls many genes involved in mitochondrial function and 
biogenesis, genes involved in assembly of the respiratory apparatus, 
constituents of the mtDNA transcription and replication machinery, 
mitochondrial and cytosolic enzymes of the heme biosynthetic pathway (Huo 
and Scarpulla 2001). It is interesting to note that NRF-1 was found 
downregulated in TS21 fetal hearts and 34 of the NEMG downregulated in the 
same hearts showed an NRF-1-binding site within their promoters (Table 2).  
 
Table 2. Mitochondrial genes downregulated in DS heart tissues with an NRF1       
binding site in their promoter regions. 
Gene name Score 
Promoter region 
position 
Binding site 
Sequence 
ECGF1 1 -13 CGCATGCGCA 
SCO2 1 -14 CGCATGCGCA 
PIN4 0,98 -282 CGCGTGCGCA 
12 
 
 
NRF1 target genes are sorted with a cut-off affinity score = 0.80.  
A second regulatory factor of mitochondrial biogenesis and function is NRF-2 
which is the human homolog of mouse Gabp gene (Scarpulla 1997; Scarpulla 
1999).  
NRF-1 and NRF-2 are binding partners for the transcriptional coactivator 
PGC1α (peroxisome proliferator-activated receptor coactivator 1α) which 
IDH3A 0,97 -24 CGCTTGCGCA 
UQCRC1 0,96 7 CGCTTGCGCG 
NDUFB8 0,96 -9 CACATGCGCA 
RPL10 0,96 -12 CACATGCGCA 
ENDOG 0,91 -161 CGCCTGCGCA 
FPGT-
TNNI3K 0,91 23 CGCATGCGCC 
SDHA 0,91 -88 CGCCTGCGCA 
UQCRC2 0,91 -264 CGCATGCGCC 
ETFB 0,9 -9 CGCCTGCGCG 
GLUD1 0,9 -31 CGCCTGCGCG 
NDUFAB1 0,9 -43 CGCCTGCGCG 
CYCS 0,9 -208 CGCAAGCGCA 
SDHB 0,9 -65 CGCATGCCCA 
HSPA9 0,89 -171 CGCATGTGCG 
MRPL15 0,88 -52 CGCGCGCGCA 
SLC25A12 0,88 -63 CGCGTGCGGA 
VDAC1 0,88 -59 TGCGTGCGCA 
HCCS 0,88 -25 CGCGTGCCCG 
IDH3B 0,87 -166 TGCTTGCGCA 
IDH2 0,86 -262 CGCTTGCGAG 
COX4NB 0,84 -292 CACGTCCGCA 
COQ7 0,81 -363 CGCCCGCGCA 
ETFA 0,81 -71 CGCCTGCCCA 
GOT1 0,81 -395 CGCCCGCGCA 
NDUFA13 0,81 -265 GGCCTGCGCA 
NDUFS2 0,81 -78 CGCCTGCGTA 
PDHA1 0,81 -165 CGCAGGCGCT 
DLAT 0,8 33 AGCCTGCGCG 
GCSH 0,8 -18 CGCCTCCGCG 
MOSC2 0,8 -6 AGCCTGCGCG 
AK2 0,8 -303 CCCACGCGCA 
13 
 
coactivates numerous transcription factors, including nuclear receptors such as 
PPARγ and PPARα, and estrogen receptor α, exerting the final effect to 
promote mitochondrial biogenesis and to regulate mitochondrial respiratory 
capacity (Leone et al. 2005; Scarpulla  2011; Scarpulla 2012). PGC-1α knock-
out mice manifest a reduction of mitochondrial number and of respiratory 
capacity in skeletal muscle (Leone et al. 2005). PGC-1α transcription and 
activity are positively regulated by Ca2+ signaling and negatively regulated by 
the corepressor RIP140/NRIP1 (Receptor interacting protein 1/Nuclear 
receptor interacting protein 1) (Scarpulla 2011).  
The functional versatility of mitochondria is paralleled by their morphological 
complexity. In certain cell types mitochondria are organized in networks of 
interconnected organelles. The ultrastructural changes in the architecture of 
mitochondria are due to differences that are established in the amount and form 
of the cristae, which result from folding of the inner membrane and can be 
either laminated or tubular, depending on the metabolic states of the organelle. 
This interconnected networks represent an efficient system to deliver energy or 
a calcium channel between different areas of the cell (De Giorgi et al. 2000; 
Skulachev et al. 2001).  
The ultrastructure and the reticular organization of the organelle are determined 
by mitochondria-shaping proteins that affect the equilibrium between fusion 
and fission processes. The mitofilin, encoded by the gene IMMT, is a 
transmembrane protein localized at the base of the cristae. IMMT down-
regulation results in a drastic change in the organization of the inner membrane 
that appears as densely packaged concentric layers and free of tubular 
connections (John et al. 2005). IMMT is downregulated in DS fetal hearts 
(Conti et al. 2007). 
 
 
Hsa21 genes: molecular basis of mitochondrial dysfunction in DS 
 
 Some Hsa21 genes that regulate mitochondrial biogenesis and function 
have been identified. The kinase DYRK1A and DSCR1/RCAN1 (Bushdid et 
al. 2003) were considered to be involved in mitochondrial dysfunction in DS. 
RCAN1 and DYRK1A genes are localized on Hsa21 and their overexpression, 
through the downregulation of NFATc genes (Figure 4), might result in the 
depression of PGC-1α expression.  
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Figure 4. Calcineurin/NFAT signaling. The entry of calcium ions into the cell activates 
the enzyme calcineurin to remove phosphate groups (P) from NFATc factors in the 
cytoplasm, allowing NFATc to enter the nucleus and to activate its target genes. However, 
once in the nucleus, NFATc can be phosphorylated, and so returns to the cytoplasm. Arron 
et al. and Gwack et al. (2006) implicated the DSCR1 and DYRK1A proteins in regulating 
the levels of NFATc phosphorylation. 
 
Another Hasa21 gene involved in mitochondrial function is RIP140, that has 
been already introduced above. 
Literature on RIP140 function and modulation in mouse models strongly 
supports the hypothesis that this gene is involved in mitochondrial dysfunction 
(Powelka et al. 2006; Seth et al. 2007; Fritah et al. 2010; Chen et al. 2012). 
RIP140 is a corepressor that interacts with nuclear receptors and regulates the 
expression of genes that control metabolic processes such as energy 
homeostasis (Mangelsdorf et al. 1995; Robinson-Rechavi et al. 2003; Lin et al. 
2005; Lelliot et al. 2006). It links nuclear receptors to chromatin remodeling 
enzymes, including the HDAC enzymes, involved in chromatin condensation 
and transcriptional repression, and this function is modulated by post-
translational modifications which include phosphorylation and methylation 
(White et al. 2008). RIP140 is also target of acetylation, that inhibits the 
recruitment the C-terminal binding protein (CtBP) (Vo et al. 2001).  
RIP140 interacts with 4 different repressive enzymatic complexes trough 4 
distinct repression domains (Figure 5). 
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Figure 5. Functional domains and sites of post translational modifications of RIP140. 
LXXLL motifs and the LXXML motif are shown in blue (from 1 to 10). Positions of the 4 
repression domains RD1–RD4 are in black. Stars indicate positions of potential sites of 
lysine acetylation and the vertical bars show positions of the interaction sites for CtBP and 
Vitamin B6. The protein contains approximately 15% serine/threonine residues and sites 
identified as phosphorylation targets (White et al. 2008) 
 
This highly conserved gene shows a 1.5- to 4-fold upregulation both in the 
heart and fibroblasts from DS subjects (Conti et al. 2007; Piccoli et al. 2013). 
The upregulation of RIP140 protein was also demonstrated in the DS 
hippocampus (Gardiner 2006) together with the upregulation of SUMO3, 
another gene mapping to Hsa21, which might modulate RIP140 repressive 
activity. Indeed, the lysines located in RIP140 repression domain 3 and 4 
represent the SUMO3 attachment consensus region and they are evolutionary 
conserved across vertebrate (Rytinki and Palvimo 2009). The simultaneous  
upregulation of both Hsa21 genes, might exert a synergistic effect.  
Powelka  et al. (2007) demonstrated that RIP140 significantly affects oxidative 
metabolism and mitochondrial biogenesis. On the contrary Seth et al. (2007) 
demonstrated that RIP140 overexpression represses nuclear mitochondrial 
genes involved in all respiratory chain complexes (Figure 6A and 6B).  
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Figure 6.  Representation of  metabolic pathways influenced by RIP140 modification. 
(A) Metabolic pathways, in gray, upregulated after RIP140 silencing in adipocytes. (B) 
Metabolic pathways downregulated, in black, after RIP140 overexpression in mouse 
adipocytes (Seth et al. 2007). 
 
The transcription factors NRF1 and ERRα and their targets are repressed by 
RIP140 and induced by PGC-1α in a dose dependent manner in neonatal rat 
cardiomyocytes (Chen et al. 2012). The PGC-1α protein, that plays a central 
role in regulating mitochondrial biogenesis and respiratory functions through 
the interaction with transcriptional partners, like NRF1, ERRα and PPARγ, is 
repressed by RIP140 (Scarpulla 2011) (Figure 7).  
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Figure 7.  Representation of  PGC-1α regulation by RIP140 and Ca2+ signaling 
(Scarpulla 2011).            
 
Conti et al. (2007) and Piccoli et al. (2013) demonstrated that PGC-1α mRNA 
is significantly downregulated in DS fetal hearts and fibroblasts, respectively, 
while RIP140 is upregulated.  
It can be hypothesized that the concurrent over expression of the Hsa21 genes 
RIP140, SUMO3, RCAN1 and DYRK1A and the downregulation of NFATc 
genes, observed in DS samples, result in the depression of PGC-1α expression. 
 
 
ANT1/SLC25A4 regulates the ADP/ATP exchange within mitochondria 
 
 Genes mapping on other chromosomes are involved in a number of 
mitochondria functional alterations. Among those some authors have 
considered the role of ANT1 in the alteration of ADP/ATP exchange in 
mitochondria (Graham et al. 1997; Palmieri et al. 2005). ANT1/SLC25A4 
(Adenine Nucleotide Translocator 1/Solute carrier family 25 member 4) is a 
dimeric protein complex of two identical 32kDa subunits embedded in the 
inner mitochondrial membrane that facilitates the transport of ADP and ATP 
(Klingenberg 1989; Fiore et al. 1998) (Figure 8). It has been demonstrated that 
ANT1 is downregulated in DS fetal hearts (Conti el al. 2007) possibly because 
it is a target of the Hsa21 miRNA let-7c. 
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Figure 8. Position of ANT1 in the inner mitochondrial membrane. ANT1 interacts with 
PTP proteins and is embedded in the inner mitochondrial membrane. It has a central role 
in the ADP/ATP exchange and regulation of apoptosis. (Bauer et al. 1999) 
 
ANT1 has a central role in OXPHOS: it acts as a solute carrier and exchanges 
matrix ATP for cytosolic ADP providing mitochondrial energy to the cytosol. 
ANT1 functions in mitochondria, which are structures within cells that convert 
the energy from food into a form that cells can use. ANT1 has also been 
proposed to participate in the formation of the mitochondrial permeability 
transition pore (PTP), a high-conductance channel of low selectivity that 
occurs on mitochondrial membranes (Zoratti and Szabò 1995; Haworth et al. 
2000). The opening of PTP allows the free passage of solutes with a molecular 
mass below 1.5 kDa, thereby leading to membrane depolarization, substrate 
depletion, equilibration of solutes across the inner membrane, swelling of 
mitochondrial matrix and rupture of the outer membrane.  
PTP is involved in programmed cell death through its action in permeabilizing 
the mitochondrial membranes. It has been demonstrated that PTP is regulated 
by ANT1 inhibitors, this suggests that ANT1 is the core pore-forming element 
of PTP. This proposal was supported by the observation that, in reconstituted 
lipid bilayers, purified ANT1 forms a large Ca2+-dependent channel resembling 
PTP. However, the contribution of ANT1 to PTP remained a matter of active 
debate due to the lack of direct in vivo evidence to support ANT1 pore 
formation ability. Also, the complexity of PTP modulation in isolated 
mitochondria does not tend to support the ANT1-based single channel model 
(Chen 2002). It has been demonstrated that an ANT1 isoform is involved in 
some mitochondrial alterations. Indeed, the complete loss of function of ANT1 
is associated to mitochondrial myopathy and cardiomyopathy. ANT1 knock out 
mouse model is characterized by a decrease of respiratory activity, increased 
redox stress and ROS production, proliferation of mitochondria and ragged-red 
fibers, heart progressive hypertrophy, metabolic abnormalities with increase of 
serum lactate level and severe exercise intolerance (Graham et al. 1997; 
Palmieri et al. 2005). Moreover, genetic inactivation of the ANT1 heart 
isoform results either in mtDNA damage and increased reactive oxygen species 
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either in dysregulation of many genes coding for mtDNA OXPHOS subunits, 
nuclear OXPHOS subunits and mitochondrial components (Subramanian et al. 
2008). Palmieri et al. (2005) demonstrated that the accumulation of mtDNA 
deletion causes, in post-mitotic tissues, some mendelian disorders such as 
adult-onset progressive external ophthalmoplegia (PEO) due to weakness of 
the external eye muscles. Most of the ad-PEO families carry heterozygous 
mutations in ANT1. 
In conclusion, it might be hypothesized that the concurrent over expression of 
the Hsa21 genes RIP140, SUMO3, RCAN1 and DYRK1A, and the 
downregulation of NFATc genes, observed in DS samples, result in the 
depression of PGC-1α expression (Figure 9). 
 
 
 
 
 
Figure 9. Hsa21 genes and transcript involved in mitochondrial pathways. Working 
hypothesis. TS21 leads to the upregulation of DYRK1A, DSCR, RIP140 and miRNA let-
7c. DYRK1A and DSCR inhibit Calcineurin/NFAT axis in its control of PGC-1α expression 
and, as a consequence, the activity of PPARγ that controls Ca2+ homeostasis. By this 
pathway, the inhibition of  PGC-1α may indirectly increase Ca2+ level. Also RIP140 may 
interfere with mitochondrial function as a consequence of the PGC-1α downregulation. The 
microRNA let-7c is involved in mitochondrial function possibly through the downregulation 
of ANT1 which regulate the ATP/ADP exchange. This miRNA may contribute to the energy 
deprivation in mitochondrial dysfunction. Finally, also the donwregulation of IMMT, caused 
by an unknown mechanism, may contribute to the alteration of mitochondrial function. 
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AIMS OF THE STUDY 
 
 The aim of this study was to characterize functional alterations of 
mitochondria in human fetal fibroblasts trisomic for Hsa21 with a special focus 
to Hsa21 transcripts possibly responsible for that. The mitochondrial 
dysfunction in DS was characterized investigating respiratory activity and 
oxidative distress. Oxygen consumption, OXPHOS complex activities, ROS 
production, membrane potential, mtCa2+ and mtDNA copy number were 
compared between trisomic and euploid fibroblasts. Mitochondrial 
ultrastructure was also analyzed on fibroblasts in order to define morphological 
alterations associated to mitochondrial dysfunction. According to literature and 
previous results, an Hsa21 gene (RIP140) and an Hsa21 miR (miR-let7c) were 
chosen for further investigations. They were both upregulated in DS-HFF as 
result of primary dosage effect. RIP140 is a corepressor deeply involved in 
mitochondrial pathways. The gene was transiently silenced in this study to 
verify its possible implication in mitochondrial dysfunction and in the 
regulation of PGC-1α expression. The aim of silencing experiments was also to 
verify whether RIP140 inhibition in DS cells is able to rescue the 
mitochondrial function. The role of Hsa21 miRNA Let-7c was investigated for 
its possible influence on the ANT1 translocator, a gene downregulated in TS21 
tissues and possibly involved in DS mitochondrial dysfunction. Our hypothesis 
is that the upregulation of a miRNA let-7c may contribute to mitochondrial 
dysfunction in DS, in particular to the alteration of ADP/ATP exchange as a 
consequence of the downregulation of ANT1, as secondary dosage effect. So 
the overexpression of let-7c as a primary gene dosage effect could cause the 
downregulation of ANT1 as a secondary effect in DS and therefore the 
dysregulation of OXPHOS genes and the alteration of ADP/ATP exchange in 
the mitochondria. This phenomenon may contribute to mitochondrial 
dysfunction that we found in DS-HFF. ANT1 is a predicted let-7c target. 
Transfection experiments of a let-7c miRNA mimic were used to investigate 
the role of this miRNA on ANT1 regulation.  
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MATERIALS AND METHODS 
 
 Functional analysis that are present in this study and that were 
published in Piccoli et al. 2013 was performed in collaboration with Professor 
Nazareno Capitanio and Dr. Claudia Piccoli from the Department of 
Biochemical Science, University of Foggia. The mtCa2+ was assessed with 
Aequorin in collaboration with Professor Paolo Pinton from the Signal 
Transduction Lab, University of Ferrara. Morphological analyses were 
performed in collaboration with Dr. Marina Prisco from the Center of 
Electronic Microscopy, University of Naples Federico II. 
 
 
Samples 
 
 Primary lines of fetal fibroblasts were used for this study. All samples 
derived from fetal heart tissues used in Conti et al. (2007) that were explanted 
from fetuses after therapeutic abortion. HFF were obtained from the Telethon 
Bank of Fetal Biological Samples at the University of Naples. According to 
protocols approved by our Institutional Ethics. For this study were used  a 
cellular model of fetal fibroblasts (HFF) from normal fetuses, 5 from euploid 
fetuses (N-HFF) and 8 from fetuses with Down Syndrome (DS-HFF) with and 
without cardiophaty (CDS-HFF and NCDS-HFF respectively) (Table 3). For 
silencing experiments 4 DS-HFF (BIO37, BIO55, BIO44 and BIO48) samples 
were used. For let-7c miRNA mimic transfection  all N-HFF samples were 
used.  
 
              Table 3. Primary lines of fetal fibroblasts used in the study 
 
 DS-HFF 
N-HFF NCDS-HFF CDS-HFF 
BIO-21 BIO-24 BIO-22 
BIO-23 BIO-37 BIO-36 
BIO-27 BIO-45 BIO-44 
BIO-29 BIO-48 BIO-55 
BIO-30   
 
 
RNA extraction and Quantitative Real-time PCR 
 
 Total RNA from each sample was extracted using TRIzol reagent 
(Gibco/BRL Life Technologies, Inc., Gaithersburg, MD) and was reverse-
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transcribed using iScript cDNA Synthesis kit (Biorad). For miRNA reverse-
transcription miScript II RT Kit (Qiagen) was used. Real-time PCR was 
performed using iQ Supermix SYBR Green 2X on the Bio-Rad iCycler 
(www.bio-rad.com) according to the manufacturer’s protocols. For miRNA 
dosage  miScript SYBR Green PCR Kit (Qiagen) was used. PCR reactions 
were performed in triplicate. The primers (MWG Biotech, Ebersberg, 
Germany) used for amplification are listed in Table 4. Primer pairs were 
designed using the Primer 3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi/) to obtain amplicons ranging from 100 to 150 
base pairs. In order to test primer efficiency, serial dilutions of cDNAs 
generated from selected samples, that expressed target genes at a suitable level, 
were used to generate standard curves for each gene. GAPDH, RPL13A and 
ABELSON housekeeping genes were chosen as reference genes. 
           Table 4. Primer sequences of genes analyzed by qRT-PCR. 
 
GENE NAME PRIMER SEQUENCES 
BTG3 
LEFT: GAGGCAGTTGAGAGGTTTGC 
RIGHT: GAGTGAGCTCCTTTGGCAAG 
ITSN1 
LEFT: GTGAGCGGCACTGATTTGT 
RIGHT: GATCATGCTTCGCTCTTTCC 
DYRK1A 
LEFT: GATATCATATGGGTCAGGTCATTTT 
RIGHT: CTGGACTGTAACATAACACAGTATGC 
SOD1 
LEFT: GCATCATCAATTTCGAGCAG  
RIGHT: CAGCCTCTGTATTATCTCCAA  
NRF1 
LEFT: AAACGGAAACGGCCTCAT 
RIGHT: CTTGCTGTCCCACACGAGTA  
IMMT 
LEFT: AGTTTGTCCTCCGTCCATTG 
RIGHT: CCACCAATACCTCCACCAAC  
PGC1α 
LEFT: ACAGAACTGAGGGACCGTTTT 
RIGHT: TTTCAAGAGCAGCAAAAGCA  
NRF2 
LEFT: CCTGAACTGGTTGCACAGAA  
RIGHT: ACAAATCATGTCCCCATCGT  
RIP140 
LEFT: TGCCGTTGACAAAAAGTCTG  
RIGHT: CTTTGACAGGTGGGAAATGC  
NDUFA1 
LEFT: CTGGCTACTGCGTACATCCA  
RIGHT: TGCGCCTATCTCTTTCCATC  
NDUFA8 
LEFT: GTCATGCCGGGGATAGTG  
RIGHT:TTAAGCACAGCAGAACTAATTTTCA  
NDUFB8 
LEFT: GCCAAGAAGTATAATATGCGTGTG  
RIGHT: GTCAGGGAGCTTCGGGTAG  
NDUFS2 LEFT: GAATGGGCACAGGAGTTTG  
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RIGHT: GGCCCAAAGTTCAGGGTAAT  
NDUFS6 
LEFT: AGAAGGTCACGCACACTGG  
RIGHT: CACGGGCTGCTCTGCTAT  
RCAN1 
LEFT: TTTGCTCAGACCTTACACATAGGA  
RIGHT: GGGAGGGGAGATCAGAAACT 
NFATC2 
LEFT: GAGTTCACATCCCAGAGTCCA  
RIGHT: GAGCACTCGATGGGGTTAGA 
NFATC3 
LEFT: CTTTGCAATGGCAAGAGGA  
RIGHT: GATGAGGCACAGGCAAAGAT 
NFATC4 
LEFT: GTGAGATCATTGGCCGAGAC 
RIGHT: CCAGGTGATGACAGTTCACG 
ANT1 
LEFT: GGGTTTCAACGTCTCTGTCC 
RIGHT: TCCAGCTCACAAAAATGTGC 
DICER 
LEFT: CTGATGGAATTAGAAGAAGCACTTAAT 
RIGHT: ACCAGGGTCCCAGAACTACC 
GAPDH 
LEFT: TGCACCACCAACTGCTTAGC 
RIGHT: GGCATGGACTGTGGTCATGAG 
RPL13A 
LEFT: CCTGGAGGAGAAGAGGAAAGAGA 
LEFT: TTGAGGACCTCTGTGTATTTGTCA 
ABELSON 
LEFT: TGGAGATAACACTCTAAGCATAACTAAAGG 
LEFT: GATGTAGTTGCTTGGGACCCA 
Left and Right primer sequences, obtained from Primer 3 software, are indicated for each 
analyzed gene. 
 
 
Measurement of the respiratory activity in intact cells 
 
 The OCR (oxygen consumption rate) was assessed in intact cells 
relying on endogenous respiratory substrates and corrected for the residual 
KCN-sensitive OCR and, therefore, attributable to mitochondrial respiratory 
chain dependent activity. Cultured cells were gently detached from the dish by 
tripsinization, washed in PBS, harvested by centrifugation at 500g for 5 min 
and immediately assessed for O2 consumption with a high resolution oxymeter 
(Oxygraph-2k, Oroboros Instruments). About 5x106 viable cells/ml were 
assayed in 50 mM KPi, 10 mM Hepes, 1 mM EDTA, pH 7.4 at 37°C; after 
attainment of a stationary endogenous substrate-sustained respiratory rate, 2 
µg/ml of oligomycin was added followed by addition of 0.5 mM of the 
uncoupler carbonilcyanide ptriflouromethoxyphenylhydrazone (FCCP) a 
potent reversible inhibitor of mitochondrial oxidative phosphorylation able to 
depolarize mitochondrial membrane potential abolishing the obligatory linkage 
between the respiratory chain and the phosphorylation system which is 
observed with intact mitochondria. The rates of oxygen consumption were 
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corrected for 2 mM KCN-insensitive respiration. The respiratory control ratio 
(RCR) was obtained dividing the rates of oxygen consumption achieved before 
and after the addition of oligomycin and the protonophoric uncoupler FCCP 
(Piccoli et al. 2007).  
 
 
Measurement of the mitochondrial respiratory chain complexes activity 
 
 The specific activities of NADH: ubiquinone oxidoreductase (complex 
I) and cytochrome c oxidase (complex IV) were assayed 
spectrophotometrically on frozen–thawn and ultrasound-treated cells in 10 mM 
Tris, 1 mg/ml serum albumin, pH 8.0. Complex I was assayed (in the presence 
of 1 µg/ml of antymicin A plus 2 mM KCN) by following the initial 2 µg/ml 
rotenone-sensitive rate of 50 µM NADH oxidation (ε340nm = 6.22 mM-1 cm-1) 
in the presence of 200 µM decylubiquinone (dUQ) as electron acceptor; the 
NADH-ferricyanide reductase activity of complex I was measured in the 
presence of rotenone, antimycin A and KCN with 200 µM potassium 
ferricyanide from the oxidation of NADH. Complex IV was assayed by 
following (in the presence of antymicin A) the initial 2 mM KCN-sensitive rate 
of 20 µM ferro-cytochrome c oxidation under aerobic conditions. The activities 
were normalized to the initial cell number and to cellular protein content (Cela 
et al. 2010).  
Citrate synthase catalyzes the reaction between acetyl coenzyme A (acetyl 
CoA) and oxaloacetic acid (OAA) to form citric acid. Citrate synthase activity 
was assayed spectrophotometrically measuring the reaction between CoA-SH 
(CoA with a thiol group) and DTNB (5,5′-dithiobis(2-nitrobenzoic acid)) to 
form 5-thio-2-nitrobenzoic acid (TNB) that absorbs at 412 nm. 
 
 
Laser scanning confocal microscopy imaging of mitochondrial membrane 
potential, ROS, Ca2+ and mitochondrial activity in live cells 
 
 Cells cultured at low density on fibronectin-coated 35-mm glassbottom 
dishes were incubated for 20 min at 37°C with the either of the following 
probes: 2µM tetramethylrhodamine ethyl ester (TMRE, a fluorescent lipophilic 
cation that accumulates in mitochondria electrophoretically) to monitor 
mitochondrial membrane potential (_Ψm); 10µM 2,7-dichlorofluorescin 
diacetate (DCF-DA a fluorescent probe H2O2sensible that selectively 
accumulates in mitochondria), which is converted to dichlorofluorescein by 
intracellular esterases (the acetate group of DCF-DA is removed by 
intracellular esterases and in the presence of superoxide ion the fluorescent is 
emitted), for detection of H2O2; 5 µM X-Rhod-1 AM for mitochondrial Ca2+. 
All probes were from Molecular Probes (Eugene, OR). Stained cells were 
washed with PBS and examined with a Nikon TE 2000 microscope (images 
collected using a 60x objective [1.4 NA]) coupled to a Radiance 2100 dual-
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laser LSCM system (Bio-Rad). TMRE and Rhod-1 red fluorescence was 
elicited by exciting with the He-Ne laser beam (λex 543 nm); whereas, 
dichlorofluorescein green fluorescence was elicited with the Ar-Kr laser beam 
(λex 488 nm). Acquisition, storage, and analysis of data were performed with 
LaserSharp and LaserPix software from Bio-Rad or ImageJ version 1.37. 
Superimposed confocal planes were analyzed by means of the “stack” function 
of the LCS-Analysis Tools, which produced an ax intensity profile of the 
average value of the pixels within marked edges, including a single cell, as a 
function of each focal plane. The integrated value of the xz profile was taken as 
a measure of the fluorescence intensity of that individual cell relative to the 
selected emission channel. Correction was made for the minimal background 
by repeating the procedure in a cell-free field. About one hundred single cells 
were analyzed for each imaging analysis (Cela et al. 2010). For the evaluation 
of ROS after RIP140 siRNA transfection 50000 cells were plated on 35-mm 
well plates (BD Falcon) on 20×20 mm slides (Delchimica). Twenty-Four hours 
later cells were incubated for 10 minutes at 37°C with 5nM of DCF-DA 
(Molecular Probes) and then washed three times with PBS 1X. Treated cells 
were observed using the confocal microscopy Zeiss Axiophot LSM 510 and  
DCF was elicited with the Ar laser  (λex 488 nm). The images were acquiring 
using a 63X objective and then were analyzed using the ImageJ version 1.37 as 
previously described.   For the evaluation of mitochondrial activity by 
Mitotracker Red (Molecular Probes). Mithotracker are  a group of fluorescent 
probes that contain chloromethyl moieties that are thought to react with free 
sulfhydryls within the cell. Since the complexes of the respiratory chain are 
embedded in the inner mitochondrial membrane and  mitochondrial activity is 
an index of mitochondrial respiration. MitoTracker Red,  a selective 
mitochondrial probe, which accumulates in actively respiring mitochondria 
was chosen. Three-thousand  cells were plated on 24 well plates on 12×12mm 
slides and then incubated with 150nM of Mitotracker Red for 30 minutes. After 
incubation cells were fixed with 4% of Paraformaldehyde for 20 minutes and 
then washed ones with PBS 1X. also for Mitotracker Red analysis confocal 
microscopy Zeiss Axiophot LSM 510  was used. Mitotracker was elicited with 
the He-Ne laser (λex 581 nm) . The images were acquiring using a 63X 
objective and then were analyzed using the ImageJ version 1.37 as previously 
described. 
 
 
Mitochondrial calcium measurement using aequorin 
 
 Aequorin is a 21-kDa protein from various Aequorea species 
(Shimomura 1986) which, in the active form, consists of an apoprotein and a 
covalently bound prosthetic group (coelenterazine). When Ca2+ ions bind to 
three high-affinity sites (EF-hand type), aequorin undergoes an irreversible 
reaction in which a photon is emitted.  
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Mitochondrial Calcium was measured by the method described by Pinton et al. 
(2007). Cells were cultured on 13 mm-diameter coverslips in Chang medium 
B+C (Irvine scientific) at 37 °C and 5% CO2 for 24 h and then infected with an 
adenoviral vector containing the plasmid with the cDNA coding for a 
mitochondrial-matrix addressed mutant form of aequorin. This construct 
includes the mitochondrial-targeting presequence of subunit VIII of human 
cytochrome c oxidase fused to the aequorin cDNA. Forty-eight hours after 
transfection, the cells were incubated for 1.5 h with 5 µM coelenterazine in 
Chang medium in a 5% CO2 atmosphere. Coverslips with the transfected cells 
was placed in a saline solution-perfused chamber at 37 °C, and the number of 
emitted photons per second was measured after the stimulation with histamine 
using a photomultiplier with amplifier-discriminator. The output of the 
amplifier-discriminator was captured by a photon-counting board in a 
microcomputer and stored for further analysis. In order to calibrate the row 
luminescent signal in terms of [Ca2+] an algorithm has been developed that 
takes into account the instant rate of photon emission and the total number of 
photons that can be emitted by the aequorin of the sample. To obtain the latter 
parameter, at the end of each experiment the cells were lysed by a hyposmotic 
medium containing 10 mM CaCl2 and 0,1% Triton X-100 in order to discharge 
all the aequorin that was not consumed during the experiment. 
 
 
Morphological analysis and stereological investigation 
 
 Fibroblasts from trisomic and euploid fetuses were fixed and embedded 
for the electron microscope, using agarose as an intermediate embedding 
medium (Hayat 1981; Kerstens et al. 2000). In the petri dishes the cells were 
fixed with 4% paraformaldehyde and 5% glutaraldehyde in PBS buffer (0.1M, 
pH7,3) for 30’ at room temperature, then washed in buffer, scraped from 
culture plates and pelleted by centrifugation for 10 min at 2000g; the 
supernatant was discarded and the cells were resuspended in 1 ml of 2% liquid 
agarose at 65°C. Again, the reaction tube was centrifuged for 5 min at 1000g to 
concentrate the cells in agarose. The agarose-cell pellet was solidified in ice for 
30 min, then the agarose cone was carefully taken out of the reaction tube and 
divided in small pieces (1 mm3). The agarose-cell blocks was post-fixed in 
osmium tetroxide (1% in PBS buffer) for 1 h at 4°C, dehydrated and 
transferred first in propylene oxide, then in a mixture of propylene oxide-Epon 
1:1 and finally embedded in Epon resin. The Epon blocks were polymerized 
for two days at 60°C and then sectioned with a diamond knife to give thin 
sections, 70-80 nm each; the sections were picked up on 200 mesh copper 
grids, stained with uranyl acetate (5% in 50% methanol) and Reynolds lead 
citrate (Reynolds 1963) and observed by transmission electron microscope 
Philips 208S. Micrographs were acquired with a Mega View II Soft Imaging 
System camera. 
27 
 
For stereological investigations we used a stereological estimator, the 
“fractionator” method, to obtain a systematic and uniformly random sampling, 
which ensures that even for relatively small samples the error is so small that it 
may safely be ignored (Gundersen 2002).  
Fifty cells per sample were analyzed and for each cell the percentages of 
broken and branched mitochondria and mitochondria with concentric or 
longitudinal cristae were determined. Furthermore, for each sample 25 
micrographs were collected to evaluate the mitochondrial volume density 
(Vmt, relative volume of mitochondria on cell volume) and mitochondrial 
cristae volume density (Vmc, relative volume of mitochondrial cristae on 
mitochondria volume) (Weibel et al. 1966). To this end, a regular point lattice 
was placed random on each micrograph, by using ImageJ 1.43 software: the 
Vmt is obtained by differential counting of the points lying on mitochondrial 
surface and the total points lying on the micrograph; Vmc is obtained by 
differential counting of the points lying on mitochondrial cristae surface and 
the total points lying on the mitochondria surface.      
 
 
Western Blot of PGC-1α 
 
 For Western Blot of PGC-1α cells were washed twice with ice-cold 
PBS and lysed in RIPA buffer (NaCl 154mM; Deoxicolic Acid 12 mM; NaF 
0.95 mM; Triton X-100 1%; SDS 2%; PMSF 2 mM) in phosphate buffer in the 
presence of protease inhibitors. The protein concentration was determined 
using the Bio-Rad protein assay (Bio-Rad Laboratories Inc., Hercules, CA, 
USA). For western blot analysis, total lysates were boiled for 5 min in 
Laemmli sample buffer and analyzed on 7.5% SDSPAGE. Gels were then 
blotted onto nitrocellulose transfer membranes (Schleicher and Shuell GmbH, 
Dassel, Germany) using a Bio-Rad apparatus. After transfer, the filters were 
blocked at room temperature for 1 h with 5% BSA in TTBS (150 mM NaCl, 20 
mM Tris-HCl pH 7.5). After washing twice with TTBS (150 mM NaCl, 20 
mM Tris-HCl pH 7.5, 0.1% Tween 20), filters were incubated overnight at 4°C 
with rabbit polyclonal primary antibody to PGC-1α (1:1000, Abcam, 
Cambridge Science Park, Cambridge, UK). The filters were washed 
extensively with TTBS and incubated for 1 h at room temperature with anti-
rabbit peroxidase-conjugated secondary antibody (Amersham, Little Chalfont, 
Buckinghamshire, UK) diluted 1:1000 in TTBS. The filters were then washed 
six times with TTBS and once with TBS and developed using an ECL Western 
Blotting Substrate detection method (Pierce, Rockford, IL, USA). For 
reprobing, the nitrocellulose filters were rehydrated and stripped for 30 min at 
37°C in restore Western blotting stripping buffer (Pierce) and washed 
extensively with TTBS. Results were standardized to alpha tubulin and 
analyzed using NIH Image J (Rasband, W.S., ImageJ, U. S. National Institutes 
of Health, Bethesda, Maryland, USA,  http://imagej.nih.gov/ij/, 1997-2012.). 
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Transfection protocol 
 
 RIP140 was transiently silenced in 4 DS-HFF (BIO48, BIO44, BIO45 
and BIO37, see Table 4)  using a pool of specific RIP140-siRNAs (ON-
TARGETplus SMARTpool, Dharmacon), with negative (ON-TARGETplus 
SMARTpool Non targeting siRNAs control, Dharmacon)  and positive controls 
(ON-TARGETplus SMARTpool, GAPD siRNAs, Dharmacon) and the 
Interferin transfection reagent (PolyplusTM) . Cells were plated on 12well plates 
in a concentration of 50000 cell/well, on 35well plates with 20mm slides 
(Delchimica) in a concentration of 50000 cell/well, on 24 well plates in a 
concentration of 30000 cells/well (BD Falcon), in order to asses respectively 
RIP140 and PGC-1α expression, ROS production, mitochondrial activity. DS-
HFF were transfected  with RIP-140 siRNAs, non-targeting siRNAs and 
GAPD siRNAs by Interferin (Polyplus TransfectionTM) using 2  
concentrations of siRNAs, 5nM and 20nM,  in order to identify an appropriate 
protocol to inhibit RIP140 expression in  DS-HFF.  Seventy-two hours after 
transfection cells were harvested and the effects of RIP140 silencing were 
evaluated using RT-PCR, DCF and  Mitotracker probes.  
For miRNA let-7c upregulation a let-7c miRNA mimic by Qiagene (miScript 
miRNA Mimics) was used. Cells were plated in a concentration of 70000/well 
on 24well plates (BD Falcon) and after 24 hours were transfected with a 
miRNA mimic using the Interferin transfection reagent (PolyplusTM). Forty-
eight hours after transfection  cells were harvested and ANT1 and DICER 
expression was evaluated. 
 
 
Bionformatic analysis  
 
 TargetScan, Pita, Miranda, Microcosm, microRNA.org and Pictar 
databases were used for let-7c target prediction. Targets in common between at 
least 2 databases were chosen. Differential expression of targets in fetal heart 
samples was analyzed using Gene Spring software v12. Metanalysis of GSE 
19836 series (De Cegli et al. 2010) from GEO repository was performed using 
Gene Spring software v12, followed by Gene Ontology functional scoring by 
Webgestalt tool (http://bioinfo.vanderbilt.edu/wegestalt/). 
 
 
Statistics 
 
 The Student’s t-test was applied to evaluate the statistical significance 
of data in this study. The significance of the differences between DS-HFF and 
N-HFF, between CDS-HFF and NCDS-HFF, and between transfected and non 
transfected cells was determined.  For stereological investigations, the data 
obtained from each samples were averaged per group (DS-HFF and N-HFF; 
CDS-HFF and NCDS-HFF) and statistical evaluation was performed by two 
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non-parametric statistical tests, the Kolmogorov-Smirnov and the Kruskal-
Wallis tests. The threshold for statistical significance (p-value) was set to 0.05. 
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RESULTS 
 
 In my PhD project the molecular, morphological and functional 
analyses were combined to study mitochondria function in DS using primary 
cultures of fetal fibroblasts (HFF) as cellular model. Part of this study was 
recently published in a paper in which we demonstrated the alteration of 
mitochondrial function and the dysregulation of some genes that control 
mitochondrial biogenesis and function in DS-HFF (Piccoli et al. 2013). The 
results of this published study are briefly reported here.  
Based on the notion that NEMG are downregulated in fetal heart tissues 
trisomic for Hsa21 (Conti et al. 2007), we investigated the molecular basis of 
this dysregulation and determined whether NEMG downregulation was 
correlated to abnormal mitochondrial function.  
To this aim we collected fetal fibroblasts (HFF) from non trisomic fetuses (N-
HFF) and from fetuses with Down Syndrome (DS-HFF) with and without 
cardiophaty (named CDS-HFF and NCDS-HFF respectively). In all HFF we 
verified by standard G-banding technique that no changes in chromosome 
number and structure had occurred in cells after thawing and culture passages. 
 
Hsa21 genes and NEMG are dysregulated in DS-HFF 
 
 The expression of Hsa21 and nuclear mitochondrial genes was analyzed 
in DS-HFF, by qRT-PCR. All Hsa21 genes analyzed were upregulated in DS-
HFF confirming the gene dosage effect previously demonstrated in DS tissues 
(Mao et al. 2005; Conti et al. 2007) (Figure 1A). For NEMG we focused to 
genes involved in mitochondrial biogenesis (NRF1 and PGC-1α) and 
morphology (IMMT), mitochondrial complex subunit genes (NDUFs) and 
genes affecting mitochondrial function through the calcineurin pathway 
(NFATc genes). Most of the investigated genes were downregulated (Figure 
1B) indicating that the NEMG dysregulation observed in DS fetal hearts (Conti 
et al. 2007) is similarly found in fibroblasts. We also demonstrated that 
NFATc3 and NFATc4 were significantly downregulated and inversely 
correlated to DYRK1A and RCAN1 in trisomic fibroblasts (Figure 2) as well 
as in fetal hearts (Conti et al. 2007). 
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Figure 1. Dysregulation of gene expression in DS-HFF. Hsa21 (A) and nuclear-
encoded mitochondrial gene expression (B) in DS-HFF versus N-HFF samples, obtained 
by qRT-PCR. Values represent the mean of three replicates ± standard error of the mean 
(SEM). * = p<0.05, ** = p<0.01, # = Not significant; N-HFF = Euploid fibroblasts, DS-HFF = 
Hsa21 trisomic fibroblasts. 
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Figure 2. DYRK1A, RCAN/DSCR1 and NFAT gene expression. The kinases DYRK1A 
and RCAN/DSCR1 are upregulated while NFATc3 and NFATc4 are downregulated in 
trisomic fibroblasts.  
 
 
The mitochondrial function is altered in DS-HFF 
 
 After assessing NEMG global downregulation in DS-HFF, a 
mitochondrial functional analysis was carried out in the same cell lines. The 
respiratory activity of N-HFF and DS-HFF samples was compared by high-
resolution oxymetry. The OCR (oxygen consumption rate) was assessed in 
HFF samples. Although an inter-individual variability was observed, on an 
average basis, the resting respiration of DS-HFF showed a significant decrease 
that was more evident in CDS-HFF (≈43% inhibition) when compared to 
controls (Figure 3). Conversely DS-HFF showed a slight increase in the OCR 
in the presence of the FoF1-ATP synthase inhibitor, the oligomycin; whereas, 
in the presence of the protonophoric uncoupler FCCP, a slight, albeit 
significant, decrease (≈27% inhibition) in the OCR was observed. These results 
indicate that the reduction of OCR in DS-HFF is dependent on the alteration of 
the electron transporting chain.  
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Figure 3.  Respirometric analysis in DS fibroblasts. The OCR (normalized to cell 
number) was assessed by high-resolution oxymetry in intact cells as described in Materials 
and Methods. A comparative analysis between five different euploid (N-HFF) and eight 
different DS-HFF samples (NCD-HFF and CDS-HFF) is shown. The endogenous OCR 
was measured under resting conditions (OCRRR), in the presence of oligomycin 
(OCROL), and in the uncoupled state in the presence of FCCP (OCRUNC).  
 
To assess whether the observed respiratory deficit resulted from a specific 
defect in one of the respiratory chain complexes we measured the activity of 
the complexes I (NADH-dehydrogenase), complex III (cytochrome c 
reductase) and complex IV (cytochrome c reductase) in DS-HFF. The activity 
of complex I was significantly reduced (by about 50%) in DS-HFF, both in 
NCDS-HFF and CDS-HFF as compared to N-HFF (Figure 4). No significant 
differences in activities of complexes III and IV in DS-HFF versus N-HFF 
were found. Complex I activity was normalized to the activity of citrate 
synthase, which is an index of mitochondrial mass, and to total protein level 
per cell. The results after normalization were unchanged. 
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Figure 4. Enzymatic activities of the mitochondrial respiratory chain complex I of DS 
fibroblasts. The specific activities of complex I (NADH-dehydrogenase) was measured in 
cell lysates under conditions of saturating substrate as described in Materials and 
Methods. Dark grey histogram shows that the activity of complex I is significantly reduced 
in DS-HFF with and without cardiophaty (light grey bar and black bar) compared to N-HFF 
(white bar). * = p<0.05.  
 
We used TMRE to measure the mitochondrial membrane potential (mt∆ψ) by 
confocal microscopy imaging. TMRE is a specific mitotropic probe. The 
fluorescent signal, due to accumulation of the probe in response to membrane 
potential, was not significantly different among the samples, but the fluorescent 
signal revealed less inter-digitated mitochondrial network morphology in DS-
HFF (Figure 5).  
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Figure 5. Confocal microscopy analysis of mt∆Ψ in DS live fibroblasts compared to 
N-HFF. Magnifications of intracellular details showing the mitochondrial functional network 
in samples N-HFF, NCDS- and CDS-HFF. A false-colours rendering of the TMRE-related 
fluorescence imaging is also shown. 
 
Mitochondria are the major source of ROS as a consequence of mitochondrial 
activity.  In particular complex I is considered one of the sites of generation of 
superoxide radicals (Li and Trush 1998; Kussmaul and Hirst 2006). The 
intracellular redox state was assessed by confocal microscopy in order to 
evaluate any alterations in ROS production possibly correlated to the electron 
transporting chain anomalies and NEMG dysregulation using the 2'-7'-dichloro 
fluorescein diacetate (DCFA-DA) probe, a H2O2 sensitive fluorescent probe 
that selectively accumulates in mitochondria. The analysis demonstrated that 
DS-HFF samples produced more ROS compared to N-HFF with a larger redox 
imbalance in CDS-HFF (Figure 6A and 6B). As shown by the enlargement 
“a”, the brighter signal of the DCF-DA related fluorescence is 
compartmentalized. 
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Figure 6. ROS production in DS-HFF versus N-HFF. (A). Confocal microscopy images 
of DCF-H2O2 indicating mitochondrial localization of superoxide radicals (green signals). 
(B). Representation of DCF-DA pixel intensity in DS-HFF versus N-HFF. Both in  NCDS-
HFF and in CDS-HFF pixel intensity of DCFA-DA is increased, most in CDS-HFF.in N-HFF 
(BIO21, BIO23, BIO27, BIO29, BIO30 white bar) (dark gray bar) and DS-HFF (NCDS-HFF-
BIO24, BIO37, BIO45, BIO48-light gray bar and DS-HFF- BIO22, BIO36, BIO44, BIO55-
black bar). Statistical analysis of the fluorescence intensity per cell as resulting from the 
averaged values ± SEM of about one hundred randomly selected different cells for each 
sample from at least in-duplicate experiments; statistical analysis of the differences is also 
shown. 
 
In order to investigate calcium signaling alterations due to the abnormalities of 
mitochondrial function and gene dysregulation, we evaluated the 
intramitochondrial calcium level (mtCa2+) using the specific probe Rhod-1, 
which is a red fluorescent probe. DS-HFF displayed a statistically significant 
more intense Rhod-1-related fluorescence signal as compared to N-HFF. The 
compartmentalization of the brighter signal reveals steady-state mtCa2+ level 
(Figure 7). 
To verify the specific mitochondrial derivation of mtCa2+ we used a different 
method based on a calcium-sensitive photoprotein, the Aequorin. Also 
Aequorin results revealed the increased concentration of mt Ca2+ in DS-HFF, 
with and without cardiophaty (Figure 8). We found a significative 40% 
calcium overload in DS-HFF samples. 
 
 
37 
 
 
 
Figure 7. Confocal microscopy analysis of Rhod-1 fluorescence. Confocal microscopy 
analysis reveals the increase of Ca2+ in DS-HFF with and without cardiophaty compared to 
N-HFF. 
 
 
 
Figure 8.  Intramitochondrial calcium measurements in DS-HFF samples with 
Aequorin. Representation of Aequorin result shows a significative 40% calcium overload 
in DS-HFF samples (dark bar), with and without cardiophaty (light gray bar and black bar 
respectively) when compared to N-HFF (white bar). Results are shown as mean of the 
determinations in each group ± SEM. *=p<0.01. 
 
We blocked the entry of Ca2+ in the mitochondria using a specific inhibitor, the 
ruthenium red (RR), which inhibits the mitochondrial calcium uniporter 
(MCU) (De Stefani et al. 2011;  Drago et al. 2011). We found that the 
inhibition of the mitochondrial Ca2+ by RR caused a substantial inhibition of 
ROS production suggesting that the entry of Ca2+ in the mitochondrial 
compartment was at least partially responsible for the redox imbalance in 
trisomic cell samples (Figure 9A and 9B). Moreover, treatment with RR 
resulted in enhancement of the respiratory activity in DS-HFF to the level of 
N-HFF (Figure 10). 
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Figure 9. Effect of ruthenium red on ROS production in DS-HFF. Cultured fetus-
derived fibroblasts representative of euploid (BIO23) and DS noncardiophatic (BIO45) or 
cardiopathic (BIO22) samples were treated with RR and then assessed by confocal 
microscopy for ROS production and mtCa2+ by DCF and Rhod-1, respectively. (A) DCF-
related fluorescence imaging of untreated and RR-treated fibroblasts (representative of 3 
different experiments). (B) Statistical analysis of the DCF-related (upper histogram) and 
Rhod-1-related (lower histogram) fluorescence intensity per cell. In the graph is 
represented the average value ±SEM of about one hundred cells for each sample from 
three different experiments. 
 
 
 
Figure 10. Effect of RR on the respiratory activity of DS-HFF. The OCR was measured 
in NCDS- and CDS-HFF (BIO45 and BIO22 respectively) with and without RR compared to 
N-HFF (BIO23). The bars are means ±SEM of the average determinations for each sample 
(untreated and RR-treated) carried out in triplicate. 
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A normal mitochondrial morphology is necessary for mitochondrial function as 
the mitochondrial cristae represent the subcellular localization of the oxidative 
phosphorylation coupled to the respiratory chain. Electron microscopy (EM) of 
trisomic fibroblasts revealed an abnormal morphology in a  significant number 
of mitochondria showing an increased size, irregular shape, evident breaks, in 
particular in the inner membrane. In addition, the mitochondria show  
alterations in the pattern of cristae: broadened and arranged concentrically or 
oriented parallel to the long axis of the organelle (longitudinal cristae) (Figure 
11A). Broken mitochondria and mitochondria with concentric and longitudinal 
cristae were significantly more abundant in trisomic samples than in the 
euploid ones with a p<0.05 (Figure 11B). Stereological analysis demonstrated 
that the mitochondrial volume density was similar in euploid and trisomic 
samples (Figure 11C) while the cristae volume density was significantly 
reduced in DS-HFF samples with a p<0.05 (Figure 11D). 
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Figure 11. Mitochondria of DS fibroblasts show morphological abnormalities. (A) 
Electron micrographs of mitochondria in DS-HFF (a-f) and in N-HFF (g, h) Scale bars: 500 
nm. (B) The percentage of anomalous mitochondria is significantly higher in trisomic 
samples (DS-HFF). (C) The mitochondrial volume density is not significantly different 
between trisomic and euploid fibroblasts. (D) The mitochondrial cristae volume density is 
almost 50% lower in DS-HFF than in the euploid samples. In all the graphs mean values ± 
SEM are shown. *=p<.05 #=not significant 
 
The assessment of mtDNA copy number is usually proportional to 
mitochondria cellular content. In DS-HFF, mtDNA copy number, measured by 
RT-PCR against nuclear DNA (nDNA) copy number, was reduced by about 
40%, if compared to N-HFF (Figure 12).  
 
 
 
41 
 
 
 
Figure 12. mtDNA copy number determination: mtDNA copy number of single sample 
and as mean are shown. In DS-HFF (dark gray bar) are reduced, both in NCDS-HFF (light 
gray bar) and in CDS-HFF (black bar), compared to N-HFF (white bar). 
 
 
Which Hsa21 gene or transcript might be responsible for mitochondrial 
dysfunction in DS? 
 
 This study focused on the role of chromosome 21 in mitochondrial 
dynsfuction. According to our working hypothesis in the introduction (Figure 
9) and   based on literature and bioinformatics investigations, we  have chosen 
for our studies the Hsa21 gene, RIP140/NRIP1 (Receptor Interacting Protein 
1/Nuclear Receptor Interacting Protein 1), and the Hsa21 miRNA let-7c.  We 
were interested on RIP140 because this corepressor possibly regulates the 
expression of some mitochondrial genes and functions, and on the microRNA 
let-7c which may contribute to mitochondrial dysfunction through the 
downregulation of ANT1 (Adenine Nucleotide Translocator 1) gene 
expression.  
 
Meta-analysis of public expression data strongly suggests that RIP140 
affects mitochondrial function 
 
 In order to investigate which overexpressed Hsa21 gene might 
dysregulate mitochondrial gene expression, we performed a meta-analysis of 
gene expression data from Gene Expression Omnibus repository 
(http://www.ncbi.nlm.nih.gov/geo), followed by Gene Ontology functional 
class scoring (http://bioinfo.vanderbilt.edu/webgestalt/) of all the lists of 
significantly dysregulated genes in DS subjects or models, putting attention to 
mitochondrial related categories and pathways. We first demonstrated that an 
enrichment of NEMG was observed in the lists of downregulated genes in 
microarray data of brain and astrocytes from DS fetuses (Mao et al. 2005, GSE 
1397 series). An interesting result cames from the analysis of the GSE 19836 
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series (De Cegli et al. 2010) derived from a mouse embryonic stem cell bank in 
which 32 orthologs of human chromosome 21 genes were individually 
overexpressed in an inducible manner. Each clone was transcriptionally 
profiled in inducing versus non-inducing conditions by Affymetrix Gene Chip 
Mouse 430_2 (RNAs were from 3 induced mouse ESCs and 3 not induced 
controls, for each Hsa21 gene). The overexpression of a corepressor gene 
mapping to Hsa21, RIP140, in mouse ESCs model causes NEMG 
downregulation as main consequence, being the mitochondria one of the most 
affected Cell Component GO category, with p<0.005 (Figure 13). The analysis 
of these 2 sets of data together with our previous findings in TS21 hearts 
demonstrated that downregulation of NEMG is a costant finding in TS21 fetal 
tissues and that the Hsa21 gene RIP140 is involved in this effect. 
 
 
 
Figure 13. Cellular component categories influenced by RIP140 upregulation in mES (De 
Cegli et al. 2010). Bar chart showing that mitochondrion category (the fourth bar) is one of 
the most influenced by RIP140 upregulation(enrichment = 98 observed genes instead of 
66 expected genes with p< 0.005).  
 
 
The Hsa21 gene RIP140 is a major regulator of PGC-1α 
 
 As the expression and function of PGC-1α, a master regulator of 
mitochondrial biogenesis and function, is regulated by RIP140 (Figure 7 in 
Introduction), we analyzed this 2 genes in DS-HFF by qRT-PCR 
demonstrating that PGC-1α is significantly downregulated, when RIP140 is 
significantly upregulated in DS-HFF compared to N-HFF (Figure 14). PGC-1α 
was downregulated also at the protein level (Figure 15A and 15B). 
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To investigate the direct effects of RIP140 modifications on PGC-1α 
expression we silenced RIP140 with a specific SMART pool of siRNA in 4 
lines of DS-HFF. qRT-PCR, performed 72h after transfection, demonstrated a 
significant inverse correlation between RIP140 silencing and PGC-1α 
upregulation in a siRNA dosage-dependent way (Figure 16).  
 
. 
 
Figure 14. Gene expression of RIP140 and PGC-1α in DS-HFF versus N-HFF. Values 
represent the average determination for 5 DS-HFF samples carried out in triplicate. ** = 
p<0.02.  P-values express significance for DS-HFF vs N-HFF comparisons  
 
        
 
 
Figure 15. PGC-1α protein expression in DS fibroblasts. (A) Western Blot analysis of 
PGC-1α protein in NCDS-HFF and CDS-HFF vs euploid samples. (B) Densitometric 
analysis of PGC-1α protein expression compared to tubulin expression and normalized to 
BIO23 (N-HFF). 
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Figure 16. RIP140 and PGC-1α expression in RIP140-silenced DS-HFF. RIP140 and 
PGC-1α expression level in non-transfected (NT) and in DS-HFF transfected with 5nM and 
20nM of RIP140 siRNA dosage. Values represent the average determination for 4 RIP140-
silenced trisomic samples carried out in triplicate ± SEM. * = p<0.05, ** = p<0.02. 
 
 
RIP140 silencing  affects mitochondrial function in DS-HFF 
 
 To investigate whether RIP140 affects mitochondrial dysfunction in DS 
through the downregulation of PGC-1α and other NEMG, we evaluated 
functional parameters in DS-HFF after RIP140 silencing compared to non 
silenced cells. We evaluated redox state of DS-HFF silenced cells measuring 
ROS production by confocal microscopy using a DCF probe as previously 
described. The intensity of DCF was measured in 4 silenced DS-HFF 
compared to non transfected DS-HFF samples and N-HFF samples. The 
fluorescent signal of DCF was up to 50% decreased in silenced DS-HFF in a 
siRNA-dosage dependent way (Figure 17A). Pixel intensity was measured in 
about 50 cells after RIP140 silencing (Figure 17B). 
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Figure 17. ROS analysis in RIP140-silenced DS-HFF. (A) Representative live cell 
imaging and statistical analysis of the DCF fluorescence intensity of N-HFF cells, non-
transfected trisomic cells (NT) and trisomic cells with 5nM and 20nM RIP140 siRNA 
dosage (green signal). (B)  Measurement of DCF pixel intensity per cell. Values represent 
the average determination for 4 RIP140-silenced trisomic samples (at least 50 randomly 
selected different cells per sample/experimental condition). * = p<10-4, ** = p<10-6.  
 
Mitochondrial activity was also evaluated by confocal microscopy using a 
MitoTracker dye. MitoTracker Red, a selective mitochondrial probe was 
chosen. Its accumulation is dependent upon membrane potential. Our aim was 
to investigate whether this parameter is correlated to RIP140 expression. 
Mitotracker fluorescent intensity was increased in DS-HFF silenced cells in a 
siRNA concentration dependent way (Figure 18A). This result was confirmed 
by the pixel intensity analysis in about 50 cells (Figure 18B).  
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Figure 18. Mitochondrial activity in RIP140-silenced DS-HFF. (A) Representative live 
cell imaging and statistical analysis of the Mitotracker fluorescence intensity of 
nontransfected trisomic cells (NT) and of trisomic cells with 5nM and 20nM RIP1140 siRNA 
dosage (red signal). (B) Measurement of Mitotracker pixel intensity per cell. Values 
represent the average determination for 4 RIP140-silenced trisomic samples (at least 50 
randomly selected different cells per sample/experimental condition). * = p<0.005, ** = 
p<0.05.  
 
 
Hsa21 MiRNA let-7c may negatively regulate mitochondrial energy 
mobilization thorough the downregulation of ANT1 
 
 Non coding Hsa21 transcripts were also evaluated. The expression  of 5 
Hsa21 miRNAs, miR-99a, miR-125b, let-7c, miR-155 and miR-802 (Figure 
19) were evaluated by RT-PCR in fetal hearts demonstrating that miR-99a, 
miR-125b, miR-let-7c and miR-155 were expressed in 18-22 weeks fetal hearts 
and miR-802 was not expressed. 
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Figure 19. Analyzed Hsa21 miRNAs. Localization on chromosome 21 of analyzed 
miRNAs in DS fetal hearts. Overexpressed miRNAs are red, miR-125b (normoregulated 
miRNA) and miR-802 (not expressed miRNA) are black. 
 
Comparing DS heart tissue to controls, we found that miR-let-7c, miR-99a and 
miR-155 were overexpressed in trisomic hearts, whereas miR-125b was 
expressed with high variability (Figure 20).  
 
 
   
Figure 20. Hsa21 microRNAs expression. Hsa21 miRNas expression in 6 DS fetal 
hearts. from 6 DS individuals, 3 with CHD (CHD samples) and 3 without CHD (DH 
samples), and 3 non-trisomic controls (NH samples). Values represent the average 
determination in 6 DS fetal hearts compared to 3 euploid hearts. 
 
As miRNAs could affect protein expression by either interfering with RNA 
translation or promoting mRNA degradation, we evaluated the mRNA 
expression of target genes of overexpressed  miRNAs by using the data set of 
our previous study (Conti et al. 2007). We have analyzed target prediction by 6 
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different softwares (TargetScan, Pita, Miranda, Microcosm, microRNA.org and 
Pictar) filtering target genes according to microarray results. Seventeen targets 
of miR-99a, 12 of miR-155 and 15 of let-7c were expressed in fetal heart and 
downregulated in trisomic samples. Based on the notion that overexpression of 
Hsa21 miRNAs can result in downregulation of specific target genes possibly 
involved in DS phenotype, we considered only the list of genes downregulated 
in DS fetal hearts. We focused the analysis on the miRNA let-7c. We found 
4583 genes possibly targeted by this miRNA. Forty-four genes were 
downregulated in trisomic hearts with a Fold Change>1,3 and p<0,05. We 
were interested to let-7c because 9 NEMG were predicted targets of this 
miRNA and downregulated in trisomic samples (Table 5). Notably, one of this 
genes was ANT1. 
    Table 5. Let-7c target genes downregulated in DS fetal hearts. 
Probe Set Fold Change p-value Gene Name Database 
205295_at 0,668 0,000318 CKMT2 Microcosm 
203858_s_at 0,765 0,0101 COX10 Pita 
215210_s_at 0,58 0,0138 E2k Pictar 
201226_at 0,651 0,016 NDUFB8 TargetScan 
211715_s_at 0,554 0,0201 BDH1 Pita 
202825_at 0,645 0,0263 ANT1 Pictar;TargetScan;Pita 
203781_at 0,75 0,0318 MRPL33 Microcosm 
211150_s_at 0,596 0,0377 DLAT Pita 
217961_at 0,754 0,0423 FLJ20551 Pita 
Nine let-7c mitochondrial target genes downregulated in DS fetal hearts including  ANT1 
(in red). 
ANT1 is predicted by 3 out of 6 databases that we used (Pictar, TargetScan and 
Pita). Since ANT1 has a central role in OXPHOS, our hypothesis was that the 
ANT1 downregulation could be an effect of the specific interaction between 
let-7c and this gene at the seed sequence. To validate this hypothesis we 
performed a transfection experiment of a let-7c mimic miRNA in normal 
fibroblasts in which ANT1 is expressed. Forty-eight hours after transfection at 
25nM dosage, ANT1 was about 1.7 fold downregulated (Figure 21). DICER 
expression was evaluated as a control, since DICER is a let-7c validated target 
(Tokumaru et al. 2008). DICER was indeed downregulated in cells transfected 
with the let-7c mimic. This result is the first confirmation of our hypothesis, 
but other experiments will be necessary to definitely validate that ANT1 is a 
let-7c target. We plan to perform the reverse experiment using miRNA 
inhibitor and a Luciferase assay.  
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Figure 24. ANT1 and DICER expression in silenced fibroblasts. ANT1 (blue bar) and 
DICER (red bar) expression after miRNA let-7c upregulation by miRNA mimic at 25nM. 
Values represent the average determination for 5 transfected samples versus non 
transfected samples. 
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DISCUSSION 
 
 
Possible causes of mitochondrial dysfunction in DS-HFF 
 
 In this study we investigated the molecular mechanisms leading to 
mitochondrial alterations in fibroblasts derived from fetuses with trisomy of 
Hsa21. These fibroblasts were from the same fetuses in which Conti et al. 
(2007) determined heart gene expression profile. Fibroblasts from trisomic 
fetuses were named DS-HFF and were divided in 2 groups according to 
presence or absence of cardiopathy, CDS-HFF and NCDS-HFF, respectively. 
First of all, NEMG expression was evaluated in DS-HFF, focusing on  genes 
involved in mitochondrial biogenesis (NRF-1 and PGC-1α), mitochondrial 
morphology (IMMT), and genes of the respiratory complexes (NDUFS2, 
NDUFS6, NDUFA8, NDUFA1 and NDUFB8). These genes were 
downregulated in agreement with the results obtained by Conti et al. (2007) in 
DS fetal hearts and by  Mao et al. (2005) in DS fetal brain. 
To test the hypothesis that the decreased NEMG expression might determine 
mitochondrial dysfunction, a survey of mitochondrial activity was performed in 
DS-HFF vs. control N-HFF. First of all, oxygen consumption rate was 
measured and it was demonstrated that the oxygen consumption was 
significantly reduced in basal, uncoupled and ATP-synthase-dependent 
respiratory conditions in DS-HFF. Noticeably, the decrease was more 
pronounced in DS fibroblasts from cardiopathic fetuses. The activity of 
complex I, complex III and complex IV was thereafter evaluated. Only the 
activity of complex I was reduced by about 50% in DS-HFF, both  in NCDS-
HFF and CDS-HFF if compared to N-HFF. A complex I deficiency is 
characteristic of other mitochondrial diseases. It was also found in mouse 
models with trisomy of chromosome 16 as well as in models of Parkinson's 
disease, suggesting that different neurodegenerative diseases may be associated 
to the same mitochondrial dysfunction (Bambrick et al. 2008).  
It is known that the activity of the complexes produces in the mitochondria the 
electric potential, ∆ψ. We found that ∆ψ was not particularly affected by 
trisomy 21, but a more detailed analysis of the fluorescent signal revealed an 
alteration of the mitochondrial network. This alteration might contribute to 
mitochondrial dysfunction because the normal mitochondrial function requires 
the conservation of fusion and fission events. 
Mitochondria have a key role in oxygen metabolism and are the major source 
of ROS formation. Complex I, in particular, controls ROS production. In order 
to investigate the possible unbalance of redox homeostasis as a consequence of 
the alteration of respiratory complexes chain in DS-HFF, ROS production was 
evaluated. DCF signal revealed the increase of ROS in DS-HFF which 
localized to an intracellular compartment resembling the mitochondrial 
network. Schuchmann (2000) and Heinemann (2000) also demonstrated that a 
Ts16 mouse model had an increased  O2--• basal generation, possibly attributed 
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to a complex I deficiency. The brightness of DCF was much increased in CDS-
HFF and this result is in accordance with the oxygen consumption rate results, 
that showed a more pronounced reduction of oxygen consumption in CDS-
HFF. The mechanism underling this phenomenon will be the subject for future 
investigations. 
As ROS production is also correlated to the overload of Ca2+ into mitochondria  
(Adam-Vizi and Starkov 2010; Feissner et al. 2009) we evaluated the 
intramitochondrial Ca2+ level in DS-HFF, using two different probes, Rhod-1 
and Aequorin. Both methods revealed an increase of Ca2+ level in DS-HFF 
compared to N-HFF with a linear positive correlation between Ca2+ and ROS 
generation in trisomic samples. Notably, blockage of the major mitochondrial 
Ca2+ transporting system resulted in substantial depression of ROS 
overproduction in DS-HFF, whereas it was ineffective in N-HFF. Moreover, 
ruthenium red treatment resulted in full recovery of the respiratory activity in 
DS-HFF. The aequorin method specifically confirmed the intramitochondrial 
localization of the increased Ca2+ level. All together, these observations would 
argue for a linkage between chronic intramitochondrial Ca2+ levels, inhibition 
of complex I and mitochondrial ROS production. Even though the causes of 
the mtCa2+ homeostasis deregulation in trisomic cells have not yet been 
completely identified, literature suggests that Ca2+ mobilization/signalling is 
correlated to PPARγ (Bush et al. 2007). This correlation might link mtCa2+ to  
PGC-1α, which is an important coactivator of the PPARs transcription factor 
family including PPARγ.  
Also the 40% decrease of mtDNA copy number that we demonstrated in DS-
HFF might be correlated to the downregulation of  PGC-1α, a master regulator 
of mitochondrial biogenesis and function (Scarpulla 2011; Scarpulla 1012). 
Druzhyna et al. (2008) demonstrated a similar mtDNA copy number decrease 
in fibroblasts from DS patients due to a defective repair of oxidative damage. 
PGC1α coactivates numerous transcription factors, including nuclear receptors 
such as PPARγ and PPARα and estrogen receptor α, exerting the final effect of 
promoting  mitochondrial biogenesis and regulating mitochondrial respiratory 
capacity (Leone et al. 2005; Scarpulla 2011; Scarpulla 2012). A key role of 
PGC-1α in the regulation of mitochondrial biogenesis and function is 
demonstrated by PGC-1α knockout mice, that show decreased mitochondrial 
number and respiratory capacity in skeletal muscle (Leone et al. 2005). 
Lastly, we must also consider that the redox imbalance demonstrated in DS 
cells might also be furtherly affected by the overexpression of the HSA21 gene 
copper-zinc superoxide dismutase (SOD1), that we found overexpressed in 
trisomic fibroblasts. Neuronal death in DS has been associated to the triplicated 
expression of SOD1, which was suggested to be involved in the oxidative 
damage of neurons (Lee et al. 2001).  
As already mentioned, normal mitochondrial morphology is necessary for 
mitochondrial function. Bersu et al. (1998) and Shukkur et al. (2006) described 
a number of alterations of the mitochondrial structure, like an unusual branched 
morphology of mitochondria, in cultured cerebellar neurons from Ts16 mice, 
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and an increased number of abnormal mitochondria, especially with broken 
cristae, in brain tissues of Ts1Cje mice. 
In this study alterations of mitochondrial morphology were demonstrated. In 
particular abnormal mitochondrial cristae were increased in DS-HFF that 
showed broken mitochondria, mitochondria with concentric and longitudinal 
cristae and decreased cristae volume density. Our hypothesis is that these 
abnormalities might be correlated to the IMMT downregulation that we found 
in DS cells and tissues. IMMT downregulation was demonstrated to cause a 
drastic change in the organization of the inner membrane, that formed 
concentric layers instead of being organized into tubular cristae (John et al. 
2005), leading to cristae patterns similar to those observed in DS samples.  
The conclusion of the published part of my PhD project (Piccoli et al. 2013) 
was that NEMG downregulation is demonstrated in fibroblasts from DS fetuses 
and that it is associated to global mitochondrial dysfunction and oxidative 
distress, more pronounced in cells derived from DS fetuses with CHD. PGC-1α  
might be a possible candidate gene responsible for the altered mitochondrial 
phenotype. PGC-1α transcription and activity are positively regulated by Ca2+ 
signaling and negatively regulated by the corepressor RIP140 (Scarpulla 2011). 
Based on these findings we formulated the hypothesis that this Hsa21 gene 
plays an important role in mitochondrial dysfunction in DS. This hypothesis 
was demonstrated in the second part of my project. 
 
Hsa21 gene RIP140 affects mitochondrial dysfunctionin DS 
 
 A high number of NEMG was found to be downregulated in the heart 
(Conti ate al. 2007), in the brain (Mao et al. 2005) as well as in fibroblasts 
(Piccoli et al. 2013) from human fetuses. This poses the question of whether 
several NEMG might be under the control of the same regulatory gene and 
how this gene is affected by trisomy of Hsa21. We focused on RIP140, a gene 
mapping to Hsa21, that codes for a corepressor protein. Literature on RIP140 
function and modulation in mouse models strongly supports this hypothesis. 
Indeed, RIP140 gene expression deeply affects the oxidative metabolism and 
mitochondrial biogenesis (Powelka et al. 2006; Seth et al. 2007; Fritah et al. 
2010; Chen et al. 2012). Genes upregulated by RIP140 silencing are 
downregulated by its overexpression (Seth et al. 2007). We formulated the 
hypothesis that the overexpression of RIP140 might contribute to the 
dowregulation of NEMG and, therefore, to mitochondrial dysfunction. RIP140 
is overexpressed in DS hearts and fibroblasts and the upregulation of RIP140 
protein was also demonstrated in DS hippocampus (Gardiner 2006) together 
with the upregulation of SUMO3, another gene mapping to Hsa21, which 
modulates RIP140 activity (Rytinki and Palvimo 2009). The simultaneous 
upregulation of both Hsa21 genes, RIP140 and SUMO3, might exert a 
synergistic effect on mitochondrial dysfunction.  
The PGC-1α protein, that plays a central role in regulating mitochondrial 
biogenesis and respiratory function through the interaction with transcriptional 
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partners, like NRF1, ERRα, PPARs and YY1, is negatively controlled by the 
co-repressor RIP140 (Scarpulla 2011). PGC-1α null mice (Leone et al. 2005; 
Mitra et al. 2012), as well as knock-in RIP140 mice (Seth et al. 2007), show 
reduced expression of mitochondrial genes in multiple tissues. Also the 
transcription factors NRF-1 and ERRα and their targets are repressed by 
RIP140 and induced by PGC-1α in a dose dependent manner, in neonatal rat 
cardiomyocytes (Chen et al. 2012).  
In the present study we observed that NRF1 and PGC-1α are significantly 
downregulated in DS-HFF while RIP140 is upregulated supporting the 
hypothesis that RIP140 controls the expression of PGC-1α in DS-HFF. The 
result of this analysis is in agreement with Powelka et al. (2006). By comparing 
the list of NEMG downregulated in DS fetal hearts (Conti et al. 2007) to 
RIP140 target genes (Seth et al. 2007) we found an overlapping higher than 
60%, being 40 genes in common between the 2 lists (Figure 1). Almost all 
these genes belong to the respiratory chain complexes (Figure 2). 
 
 
Figure 1. Venn Diagram of the lists of NEMG affected by RIP140 upregulation (Seth et al., 
2007) and of NEMG dowregulated in DS fetal heart tissue (Conti et al., 2007) 
demonstrates an overlap higher than 60%. 
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Figure 2. Most of the overlapping genes from the Venn Diagram shown  in Figure 14 are 
included in all the respiratory chain complexes (blue boxes ). 
 
To validate the hypotheses we formulated about RIP140 role, we transiently 
silenced the gene in trisomic fibroblasts. Silencing experiments demonstrated 
an inverse correlation between RIP140 and PGC-1α also in trisomic cells. 
Furthermore, ROS production was decreased and mitochondrial activity was 
increased in silenced DS-HFF, demonstrating that RIP140 inhibition is able not 
only to increase PGC-1α, but also to promote at least a partial rescue of 
mitochondrial function   
All these data reinforce the hypothesis that RIP140 plays a key role in DS 
mitochondrial dysfunction.  
 
 
Hsa21 MicroRNA let-7c may contribute to mitochondrial dysfunction in 
DS 
 
 The adenine nucleotide translocator-1 plays an important role in the 
regulation of the intracellular energetic balance by facilitating the exchange of 
extramitochondrial ADP and intramitochondrial ATP. There are 4 isoforms of 
this gene, but only the isoform 1, mainly expressed in the heart, is a predicted 
target of the Hsa21 miRNA let-7c, as resulted by interrogating 6 miRNA 
prediction databases. ANT1 is downregulated in DS fetal heart and fibroblasts, 
in which Let-7c is upregulated. 
qRT-PCR after let-7c upregulation showed an inverse relationship as ANT1 
was downregulated. Based on this finding the reverse experiment using the let-
7c miRNA inhibitor is ongoing. Furthermore, a luciferase assay experiment 
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will be performed to validate the specific interaction between ANT1 3’ UTR 
and miRNA let-7c using. HeLa cells will be co-transfected with let-7c mimic 
and a vector containing the ANT1 3’ UTR downstream of the Luc gene.  
In conclusion we have demonstrated that RIP140 silencing is responsible for 
the upregulation of PGC-1α and for the partial rescue of mitochondrial function 
in DS-HFF, in particular for the reduction of ROS production and the increase 
of mitochondrial activity. We have also demonstrated that let-7c upregulation 
causes the downregulation of ANT1 so it is possibly responsible for the 
alteration of mitochondrial energy production in DS.  
Our results suggest that the upregulation of RIP140 together with the 
upregulation of let-7c, DYRK1A and RCAN1, according to our working 
hypothesis (Figure 9 in Introduction), might represent the molecular alterations 
leading to mitochondrial dysfunction in DS. 
 
 
The results of this study might be translated in DS therapy 
 
 This study provides the basis for clinical trials aimed to restore 
mitochondrial function in DS subjects to counteract specific phenotypic 
features such as the neurodegeneration. So far, few therapeutic approaches 
have been undertaken in this direction mainly based on the use of antioxidants 
and nutraceutics with poor results. New therapies could be based either on 
inhibition of RIP140 by specific RNAi or on the use of drugs affecting genes 
involved in the same dysregulated pathways.  
Gene therapy in DS is opening new scenarios using RNAi as a tool to silence 
specific genes in biological systems. A first approach might be to silence 
RIP140 in a  Dp(16)1Yey/+, a mouse model of DS with 3 copies of RIP140, 
using a non viral systems, based on cationic lipids, polymers, dendrimers or 
different types of nanoparticles. These vectors have been demonstrated to be 
non immunogenic, easy to prepare and non expensive (Alvarez-Erviti et al. 
2011). The siRNA of interest may be complexed to liposomes and to the rabies 
virus glycoprotein (RVG) (Kumar et al. 2007) that enables transvascular 
delivery of siRNAs into the brain across the blood brain barrier and binds 
specifically toacetylcholine receptors (AchRs) on neural cells. New 
improvements are continuously proposed for these techniques (Zabel  2013; 
Pulford et al. 2010; Tao et al. 2012). 
The other possible therapeutical approach to counteract mitochondrial 
dysfunction in DS might be based on drugs such as PGC-1α activators and 
PPARγ agonists. These drugs are already routinely used in clinical practice for 
treatment of metabolic syndromes, Type 2 Diabetes, and neurodegenerative 
diseases such as Alzheimer disease. Pharmacological activators of PGC-1α, 
such as metformin, via AMPK induction, as well as resveratrol, via SIRT1 
induction (Rodgers et al. 2005), have been tested in other disease mouse 
models (Dong et al. 2007; Lagouge et al. 2006; Jager et al. 2007).  On the other 
hand thiazolidinediones, such as pioglitazone and rosiglitazone, selectively 
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stimulate PPARγ. In Alzheimer disease mouse models this drugs demonstrated 
to attenuate mitochondrial dysfunction, as well as bezafibrate, another PPARγ 
agonist (Bastin et al. 2008; Nicolakakis et al. 2008; Escribano et al. 2009; Johri 
et al.  2011; Sauerbeck et al. 2011; Yamaguchi et al., 2012).  
We expect that therapeutic interventions based on these assumptions might 
improve the life quality and expectancy of DS subjects. 
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Trisomy of chromosome 21 is associated to congenital heart defects in ∼50% of affected newborns.
Transcriptome analysis of hearts from trisomic human foeti demonstrated that genes involved inmitochondrial
function are globally downregulatedwith respect to controls, suggesting an impairment ofmitochondrial func-
tion.We investigated here the properties ofmitochondria in fibroblasts from trisomic foeti with andwithout car-
diac defects. Together with the upregulation of Hsa21 genes and the downregulation of nuclear encoded
mitochondrial genes, an abnormal mitochondrial cristae morphology was observed in trisomic samples.
Furthermore, impairment ofmitochondrial respiratory activity, specific inhibition of complex I, enhanced react-
ive oxygen species production and increased levels of intra-mitochondrial calcium were demonstrated.
Seemingly, mitochondrial dysfunction was more severe in fibroblasts from cardiopathic trisomic foeti that
presented a more pronounced pro-oxidative state. The data suggest that an altered bioenergetic background
in trisomy21 foetimightbeamong the factors responsible for amoreseverephenotype.Since themitochondrial
functional alterations might be rescued following pharmacological treatments, these results are of interest in
the light of potential therapeutic interventions.
INTRODUCTION
Down syndrome (DS) is characterized by a complex pheno-
type in which over 80 features occur with various degrees of
expression and frequency (1). DS is a major cause of congeni-
tal heart defects (CHD) mainly endocardial cushion defects,
the most frequent being atrioventricular canal defects followed
by ventricular septal defects and tetralogy of Fallot (2). By
comparing the gene expression profiles of 10 human hearts
from trisomic foeti to five foetal hearts of non-trisomic
controls, we previously demonstrated a global upregulation
of chromosome 21 (Hsa21) genes and a dysregulation of
400 genes localized on other chromosomes (3). Microarray
analysis clearly showed the downregulation of genes encoding
all five mitochondrial complex subunits and of genes impli-
cated in mitochondrial biogenesis. This suggested that the cor-
responding proteins and enzymatic activities might be reduced
in DS subjects and that mitochondrial function could be con-
sequently impaired.
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Trisomy of chromosome 21 has been associated with mito-
chondrial dysfunction in cells and tissues from DS subjects
(4–6) and in mouse models (7,8). These results led to the hy-
pothesis that mitochondrial dysfunction contributes to the DS
phenotype. Protein levels of mitochondrial complexes I, III
and V were decreased in cerebellar and brain regions of DS
subjects (9). Complex I was also deficient in mouse models
of trisomy of chromosome 16. The results were similar to
those obtained from models of Parkinson’s disease, suggesting
that different neurodegenerative diseases may be associated
with the same mitochondrial dysfunction (10).
Recently, it has been also reported that the mitochondrial
energy production apparatus was less efficient in foetal DS
fibroblasts, due to the dysregulation of adenine nucleotide
translocator, ATP synthase and adenylate kinase, and a select-
ive deficit of complex I, which contributes to reactive oxygen
species (ROS) overproduction in DS mitochondria. These
events were attributed to changes in the cAMP/PKA signalling
pathway (11,12), which is known to affect the abundance of
the transcriptional coactivator PGC-1a (peroxisome
proliferator-activated receptor gamma coactivator 1-alpha).
This protein, that plays a central role in regulating mitochon-
drial biogenesis and respiratory function through the inter-
action with transcriptional partners, like NRF1, ERRa,
PPARs and YY1, is negatively controlled by the co-repressor
RIP140, a gene mapping to Hsa21 (13).
Even though these results are indicative of widespread
mitochondrial dysfunction in DS, molecular studies have not
yet been performed to investigate the basis of mitochondrial
dysfunction at the transcriptional level. Furthermore, no
hypotheses have been formulated about the mechanisms by
which trisomy of Hsa21 genes might induce such a dysfunc-
tion.
The original contribution of the present study consists of a
contemporary analysis of mitochondrial features at the mo-
lecular, morphological and functional level in 13 human
primary lines of foetal fibroblasts (HFF) derived from Hsa21
trisomic foeti, with or without CHD, and from euploid con-
trols. The mitochondrial defects associated with DS were ana-
lysed taking into account the regulation of the Hsa21 and
mitochondrial-related genes and the cardiac phenotype, in
order to identify pathways involved in mitochondrial function
and dysrupted by the Hsa21 trisomy. A striking and more
severe ROS- and Ca2+-related mitochondrial dysfunction
emerged in cardiopathic-derived Hsa21 trisomic fibroblasts,
unveiling a more pronounced pro-oxidative state.
RESULTS
The present study combines the molecular, morphological and
functional analyses of mitochondria in 13 human primary cul-
tures of HFF. Five were from euploid foeti (N-HFF, N stand-
ing for normal), and eight (DS-HFF) were derived from Hsa21
trisomic foeti [four samples from DS foeti with heart defects,
named CDS-HFF (CDS standing for Cardiopathic Down Syn-
drome), and four samples from DS foeti without heart defects,
named NCDS-HFF (NCDS standing for Non Cardiopathic
Down Syndrome)].
Gene expression is dysregulated in DS-HFF samples
The analysis of HFF karyotypes demonstrated that all trisomic
fibroblasts showed three copies of Hsa21 as the only cytogen-
etic alteration (data not shown). The expression of some
Hsa21 genes was determined by quantitative real-time PCR
(qRT-PCR) experiments comparing DS-HFF versus N-HFF.
In particular, the Hsa21 genes BTG3, SOD1, ITSN1,
DYRK1A, NRF2 and RIP140 were upregulated in trisomic
fibroblasts when compared with controls (Fig. 1A), thus con-
firming the gene dosage effects that was previously demon-
strated in human foetal tissues (3,14). We then focused on
genes that mapped to chromosomes different from Hsa21
and were involved in multiple mitochondrial functions, such
as the respiratory chain, mitochondrial biogenesis and morph-
ology, and genes involved in related pathways, such as the
Calcineurin/NFAT (Nuclear factor of activated T-cells) axe.
Most of the analysed genes were significantly downregulated
in trisomic versus euploid fibroblasts (Fig. 1B), demonstrating
that trisomy of chromosome 21 perturbs the expression of
genes involved in mitochondrial pathways. Moreover,
NFATc3 and NFATc4 were significantly downregulated
while DYRK1A and RCAN1, two Hsa21 genes involved in
regulating the levels of NFATc phosphorylation, were upregu-
lated in trisomic versus euploid fibroblasts (Fig. 1C).
Mitochondria of DS-HFF show morphological
abnormalities
Electron microscopy (EM) of trisomic fibroblasts revealed that
a significant number of mitochondria had an abnormal morph-
ology, showing an increased size, irregular shape, evident
breaks, mainly of inner membranes. In addition, the mitochon-
dria showed alterations in the pattern of cristae where some
were broadened and arranged concentrically or oriented paral-
lel to the long axis of the organelle (longitudinal cristae)
(Fig. 2A). Broken mitochondria and mitochondria with con-
centric and longitudinal cristae were significantly more abun-
dant in trisomic samples than in the euploid ones (P , 0.05)
(Fig. 2B). Stereological analysis demonstrated that the mito-
chondrial volume density, expressed as a percentage of cellu-
lar volume, was similar in euploid and trisomic samples while
the cristae volume density, expressed as a percentage of mito-
chondrial volume, was significantly lower in all DS-HFF
samples when compared with N-HFF (P , 0.05) (Fig. 2C
and D).
The functional mitochondrial phenotype is altered
in CDS-HFF
Endogenous oxygen consumption rate in intact HFF
The respiratory activity of N-HFF and DS-HFF samples
was compared by high-resolution oxymetry. The oxygen con-
sumption rate (OCR) was assessed in intact cells relying
on endogenous respiratory substrates and corrected for the re-
sidual KCN-sensitive OCR and, therefore, attributable to mito-
chondrial respiratory chain-dependent activity. Figure 3A
shows the results of a systematic analysis whereby the activity
of each cellular sample was measured. Although a relatively
large inter-individual variability was observed within each of
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the three groups, on an average basis, the resting respiration of
DS-HFF showed a significant decrease that was more evident
in CDS-HFF (≈43% inhibition) when compared with N-HFF.
Conversely, a slight increase in the OCR in the presence of the
FoF1-ATP synthase inhibitor oligomycin was observed in
DS-HFF, whereas in the presence of the protonophoric uncou-
pler FCCP a slight, albeit significant, decrease (≈27% inhib-
ition) in the OCR was observed in CDS-HFF when
compared with N-HFF. The respiratory control ratio (RCR),
attained by dividing the uncoupled OCR by that in the pres-
ence of oligomycin, was as high as 14–16 irrespective of
the cell group analysed (Fig. 3B). The ATP-synthase inde-
pendent OCR (leak) was unchanged between N- and
DS-HFF, whereas the oxidative phosphorylation-dependent
OCR (OXPHOS) was significantly reduced in DS-HFF, and
more specifically in CDS-HFF, by 36% when compared with
N-HFF (Fig. 3B). The decrease in OCRRR, observed in
DS-HFF, individually correlated to the altered mitochondrial
morphology and cristae volume density assessed by EM
(Fig. 3C). Next, we measured the mitochondrial membrane
potential (DCm) by confocal microscopic imaging using the
specific mitotropic probe TMRE. A significant difference
was not observed in the TMRE-related fluorescence among
N-HFF, NCDS-HFF and CDS-HFF (Fig. 4A), even though a
finer analysis of the fluorescent signal revealed a less inter-
digitated mitochondrial network morphology in DS-HFF
(Fig. 4B).
Complex I activity
To assess if the observed respiratory deficit in DS-HFF
resulted from a specific defect in one or the other of the re-
spiratory chain complexes, the activity of the protonmotive
complexes I, III and IV was measured in cell lysates. The ac-
tivity of citrate synthase, which is an index of mitochondrial
mass, was also measured. Figure 5A shows that the activity
of complex I was significantly depressed (by about 50%) in
both NCDS-HFF and CDS-HFF when compared with
N-HFF. The decreased activity of complex I correlated with
the altered mitochondrial cristae morphology. Conversely, sig-
nificant differences in activities of complexes III and IV were
not observed among the three cell groups (Fig. 5B and C).
Likewise, the citrate synthase activity was practically un-
affected (Fig. 5D); therefore, following normalization to the
mitochondrial mass, the selective inhibition of complex I in
trisomic cells was confirmed (data not shown). Total protein
levels per cell were slightly less in trisomic samples but not
to a statistically significance degree compared with N-HFF
(Fig. 5E).
Mitochondria-related ROS production
Intracellular ROS level was assessed by confocal microscopy
imaging of cells treated with the redox-sensitive fluorescent
probe DCF. Every trisomic sample displayed an enhanced
ROS production when compared with N-HFF, with a larger
redox imbalance in CDS-HFF (Fig. 6A). Enlargement of the
confocal images showed a compartmentalized, brighter
signal of the DCF-related fluorescence with a very low vari-
ability within each group. On an average basis, the ROS-
related DCF fluorescence was much larger in CDS-HFF
when compared with NCDS-HFF (Fig. 6B). Plotting the
DCF fluorescence versus the normalized complex I activity
for each individual HFF sample suggested the presence of a
threshold value of complex I activity below which extra-ROS
production was generated (Fig. 6C). To further ascertain the
source of the ROS release in DS-HFF, cells were treated
with DPI, which is a pan-inhibitor of flavin-containing oxi-
dases (including complex I). DPI treatment was associated
with a marked decrease in the ROS over-production in repre-
sentative samples of both NCDS- and CDS-HFF, whereas it
was ineffective in N-HFF (Fig. 7). Production of ROS by
the respiratory chain complex I is fostered by the presence
of a DCm (15). Short-time incubation of cells with the uncou-
pler FCCP significantly inhibited ROS release both in NCDS-
and CDS-HFF with a larger effect in the latter (Fig. 7). It has
been recently reported that alteration of PKA-dependent sig-
nalling affects functioning of the oxidative phosphorylation
(OXPHOS) system (11,16,17). Treatment of cells with the
cAMP analogue db-cAMP significantly reduced ROS produc-
tion in both NCDS- and CDS-HFF although the redox state,
especially in CDS-HFF, was not fully renormalized to the
level of N-HFF (cf. Fig. 7 with 6B).
Figure 1. Gene expression is dysregulated in DS fibroblasts. Gene expression
fold change in DS-HFF samples versus N-HFF samples for Hsa21 genes (A),
nuclear-encoded mitochondrial genes (B) and calcineurin/NFAT-related genes
(C) as obtained by qRT-PCR. Values represent the mean of three replicates+
SEM. ∗P , 0.05, ∗∗P, 0.01, N-HFF, Euploid fibroblasts; DS-HFF, Hsa21
trisomic fibroblasts.
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Steady-state intra-mitochondrial calcium level
Deregulation of Ca2+ homeostasis and Ca2+-mediated signal-
ling has been described in cells derived from trisomic patients
or in murine models of DS (18–20). Mitochondria are known
to function as a Ca2+ buffer by taking up Ca2+ mainly via a
specific ruthenium red (RR)-inhibitable uniporter (21,22). To
verify this point, we evaluated the intramitochondrial level
of calcium (mtCa2+) using the specific probe Rhod-1.
Figure 8A and B shows representative confocal microscopic
images of the analysis along with statistical evaluation of
the results. It is shown that DS-HFF displayed a statistically
significant more intense Rhod-1-related fluorescence signal
when compared with N-HFF. However, this was mainly con-
tributed by the CDS-HFF samples. Closer examination of the
intracellular fluorescence unveiled a compartmentalization of
the brighter signal confirming that it was largely displaying
the steady-state mtCa2+ level. The enhanced mtCa2+ load in
DS-HFF correlated positively with the increase in ROS pro-
duction (Fig. 8C) consistent with the notion that calcium
entry in mitochondria induces redox state alterations (23).
To verify the interplay between calcium and ROS, represen-
tative trisomic samples were treated with RR and the redox
Figure 2. Mitochondria of DS fibroblasts show morphological abnormalities. (A) Electron micrographs of morphologically abnormal mitochondria in DS-HFF
(a–f) and normal mitochondria in N-HFF (g and h); (a and b) broken mitochondria; (c and d) mitochondria with concentric cristae (arrow); (e) mitochondria with
longitudinal cristae (arrow head); (f) mitochondria with significantly reduced cristae; (g and h) mitochondria with unchanged morphology in N-HFF. Scale bars:
500 nm. (B) Percentages of mitochondria with abnormal morphology in fibroblasts. (C) Mitochondrial volume density relative to cell volume. (D) Mitochondrial
cristae volume density relative to mitochondrial volume. In (B)–(D), the mean values+SEM are shown along with statistical analysis; ∗P significant cut
off, 0.05 Kolmogorov–Smirnov and Kruskall–Wallis tests. N-HFF, euploid fibroblasts; DS-HFF, Hsa21 trisomic fibroblasts; NCDS-HFF, Hsa21 trisomic
fibroblasts from DS foeti without heart defects; CDS-HFF, Hsa21 trisomic fibroblasts from DS foeti with heart defects.
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state assessed by DCF. As shown in Figure 9A and B, inhib-
ition of the mitochondrial Ca2+ porter by RR caused a sub-
stantial inhibition of ROS production, suggesting that the
entry of Ca2+ in the mitochondrial compartment was at least
partially responsible for the redox imbalance in trisomic cell
samples. Moreover, treatment with RR resulted in enhance-
ment of the respiratory activity in DS-HFF to the level of
N-HFF (Fig. 9C). Similar results were obtained evaluating
mitochondrial calcium levels by a different method based on
a calcium-sensible photoprotein, the aequorin (see Supplemen-
tary Material, Text S1 and Fig. S1).
Mitochondrial biogenesis is affected by Hsa21 trisomy
Lastly, to verify if the observed mitochondrial dysfunction
was associated to a decreased mitochondrial biogenesis, we
quantified the copy number of mitochondrial DNA by absolute
qRT-PCR. There was an average value of 600 copies per
nuclear genome (i.e. per cell) in N-HFF, 500 in NCDS-HFF
and 400 in CDS-HFF (Fig. 10A). A statistical significance
was attained only for CDS-HFF.
As the mtDNA replication is controlled by PGC-1a, which
is a master regulator of mitochondrial biogenesis (13), we ana-
lysed the correlation between PGC-1a expression and the
amount of mtDNA. The amount of PGC-1a gene transcripts
was reduced by 40–50% in trisomic samples versus
N-HFF (Fig. 10B). Western blotting of PGC-1a confirmed
at the protein level a significant decrease in NCDS-HFF and
an even more marked decrease in CDS-HFF when compared
with N-HFF (Fig. 10C). A direct correlation between
PGC-1a expression and amount of mtDNA was observed in
our samples (Fig. 10D).
DISCUSSION
We previously demonstrated that more than 80 genes, encod-
ing mitochondrial enzymes and respiratory chain subunits, are
downregulated in foetal trisomic heart tissues (3). Of these
genes, 40 % have consensus DNA binding sites for the
nuclear respiratory factor NRF1 in their 5’ flanking regions,
and 20 % of them show a high affinity for the oestrogen-
related receptor ERRa (see Supplementary Material, Text S2
and Tables S3 and S4). It has been recently demonstrated
that the transcription factors NRF1 and ERRa and their
targets are repressed by Hsa21 gene RIP140 and induced by
PGC-1a in a dose dependent manner in neonatal rat cardio-
myocytes (24). Our results indicate that NRF1 and PGC-1a
are significantly downregulated in DS HFF. Western blotting
of PGC-1a confirmed the downregulation also at the protein
level in trisomic fibroblasts. This downregulation correlated
well with the downregulation of complex I activity and with
the mtDNA copy number decrease (more evidently in
CDS-HFF). PGC-1a function has been investigated in
several specialized cell types and transgenic mouse models,
demonstrating its role in the regulation of mitochondrial oxi-
dative metabolism. PGC-1a null mice show reduced expres-
sion of mitochondrial genes in multiple tissues (25,26).
PGC-1a controls the expression of nuclear-encoded mito-
chondrial genes through interactions with its transcriptional
partners NRF1 and ERRa, which are also downregulated in
DS samples.
Morphological analysis of mitochondria in trisomic versus
euploid samples demonstrated ultrastructural changes in
DS-HFF mitochondria. These results provide additional evi-
dence of altered mitochondrial morphology observed in DS
brain tissues and mouse models (8,27). Silencing experiments
demonstrated that the downregulation of IMMT causes a
drastic change in the organization of the inner membrane
Figure 3. Respirometric analysis in DS fibroblasts. (A) OCRs normalized to
cell number were assessed by high-resolution oxymetry in intact cells as
described in the Materials and Methods. A comparative analysis between
five different euploid (N-HFF) and eight different trisomic (DS-HFF)
samples is shown; a distinction of the DS-HFF between non-cardiopathic
(NCDS-HFF, n ¼ 4) and cardiopathic (CDS-HFF, n ¼ 4) foetus-derived fibro-
blasts is also reported. The endogenous OCR were measured under resting
conditions (OCRRR), in the presence of oligomycin (OCROL) and in the
uncoupled state in the presence of FCCP (OCRUNC). (B) Respiration-linked
bioenergetic parameters computed by the OCR measurements shown in (A).
RCR, respiratory control ratio; Leak, non-ATP-synthase-controlled respiratory
activity; OXPHOS, ATP-synthase-controlled respiratory activity. The bars in
(A) and (B) are means+SEM of the average determinations for each
sample carried out at least in triplicate; when statistically significant, the dif-
ference when compared with the euploid samples is shown. (C) Correlation
plots between respiratory activity under resting conditions (OCRRR) and per-
centage of concentric or longitudinal cristae or of cristae volume density for
individual fibroblast samples (see the symbol legend).
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that formed concentric layers instead of organizing into
tubular cristae (28,29), leading to cristae patterns similar to
those observed in DS samples. It is interesting to note that
IMMT is significantly downregulated in DS fibroblasts.
Mitochondria have a key role in oxygen metabolism and
subsequently they are the major source of ROS formation.
Respirometry experiments conducted in this study demon-
strated that in DS fibroblasts the OCR was significantly
reduced in basal, uncoupled and ATP-synthase-dependent
respiratory conditions, thus suggesting an impairment in oxi-
dative phosphorylation competence, especially pronounced
in DS fibroblasts from cardiopathic foeti. A correlation
between the reduced respiratory activity and the morphologic-
al alterations in DS-HFF mitochondria indicates that the
occurrence of de-structured cristae might partly account for
the dysfunctioning oxidative phosphorylation in trisomic
Figure 4. Confocal microscopy analysis of mtDC in DS live fibroblasts. (A) Representative LSCM imaging of the TMRE-related fluorescence of euploid
(N-HFF) and DS (NCDS-HFF and CDS-HFF) fibroblasts. The horizontal histograms on the right show the statistical analysis of the fluorescence intensity
per cell as resulting from the averaged values+SEM of about 100 randomly selected different cells for each sample from at least in-duplicate experiments.
(B) Magnifications of intracellular selected details showing the mitochondrial functional network in representative samples of N-, NCDS- and CDS-HFF. A
false-colours rendering of the TMRE-related fluorescence imaging is also shown.
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samples as also suggested by other authors (30,31). The ana-
lysis of individual complexes in the mitochondrial respiratory
chain showed a strong reduction in the activity of complex I in
DS fibroblasts irrespective of whether they were derived from
cardiopathic trisomic foeti. Similar results have been recently
reported (11). The authors attributed the reduced activity of
complex I to defective cAMP/PKA-dependent phosphoryl-
ation. The impact of the OXPHOS decrease observed in DS
fibroblasts did not result, however, in a severe bioenergetic
failure compromising cell growth. This could be explained
by an adaptive compensatory increase in the glycolytic flux,
as shown in ref. (12), and by the gene-dosage effect of the
Hsa21-harbored regulatory glycolytic enzyme phosphofructo-
kinase PFKL (32).
In the present study, we observed a remarkable alteration in
the redox homeostasis in DS-HFF highlighted by an increased
production of ROS, which localized to an intracellular
compartment resembling the mitochondrial network and
was sensitive to the FCCP uncoupler and to the complex I in-
hibitor DPI. These two features would point to complex I as a
major ROS generator in DS-HFF sustained by a ‘forward
electron transfer’ mechanism (33,34). ROS production in
DS-HFF was substantially suppressed by db-cAMP treatment,
supporting the hypothesis that deregulation of post-
translational modification of complex I is involved in the
redox imbalance observed in DS-HFF.
A feature emerging from the present study is that the redox
imbalance observed in DS-HFF was much larger in fibroblasts
from cardiopathic foeti irrespective of the similar degree of in-
hibition of complex I in NCDS- and CDS-HFF. Release of
ROS has been repetitively reported to be associated with an
overload of Ca2+ into the mitochondria, although the mechan-
ism remains to be satisfactorily explained (35,36). Consistent
with this notion, we observed that DS-HFF displayed a
higher steady level of intramitochondrial Ca2+ when com-
pared with N-HFF, with the CDS-HFF exhibiting the highest
mtCa2+. A linear positive correlation was found between
mtCa2+ and ROS generation in the three cytotype samples.
Most notably, blockage of the major mitochondrial Ca2+-
transporting system resulted in substantial depression of
ROS overproduction in DS-HFF, whereas it was ineffective
in N-HFF. Moreover, ruthenium red treatment resulted in
full recovery of the respiratory activity in DS-HFF. All to-
gether, these observations would argue for a linkage
between chronic intramitochondrial Ca2+ levels, inhibition
of complex I and mitochondrial ROS production. Although
Figure 5. Enzymatic activities of the mitochondrial respiratory chain complexes of DS fibroblasts. The specific activities of (A) complex I (NADH-
dehydrogenase), (B) complex III (cytochrome c reductase), (C) complex IV (cytochrome c reductase) were measured in cell lysates under conditions of satur-
ating substrate as described in the Materials and Methods. The inset in (A) shows the correlation plot of the complex I activity versus either the OCRRR (left Y
axe) and the cristae morphological features (right Y axe; L.C., longitudinal cristae; C.C., concentric cristae); the values are means+SEM of the clustered N-,
NCDS- and CDS-HFF (same colour as the horizontal bars of the histogram). The citrate synthase activity, a marker of the mitochondrial content and the amount
of protein per cell number are also shown in (D) and (E), respectively. N, DS, NCDS and CDS refer to the fibroblast sampling described in the legend of Figure 3;
the bars are means+SEM of the average determinations for each sample carried out in triplicate; when statistically significant, the difference when compared
with the euploid samples is shown.
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we have not specifically addressed the cause of the Ca2+
homeostasis deregulation in trisomic cells, a survey of the lit-
erature suggests that cross-talk between PPARg and Ca2+ mo-
bilization/signalling (37) may be likely in this case. PGC-1a is
an important coactivator of the PPARs transcription factor
family, mainly PPARg (38,39). Depression of PGC-1a activ-
ity, observed in DS-HFF samples, would consequently affect
the transcriptional efficiency of PPARs-controlled genes.
PGC-1a function is both antagonized and regulated by a
gene mapping to Hsa21, the nuclear receptor interacting
protein RIP140. This highly conserved gene shows a 1.5- to
4-fold upregulation both in the heart and fibroblasts from DS
subjects. The upregulation of RIP140 protein was also demon-
strated in the DS hippocampus (40). In the same experiment,
the authors demonstrated that SUMO3 (another gene
mapping to Hsa21) is also upregulated in these cells. It was
Figure 6. Confocal microscopy analysis of ROS production in DS live fibroblasts. (A) Representative LSCM imaging of the DCF-related fluorescence of euploid
(N-HFF) and DS (NCDS-HFF and CDS-HFF) fibroblasts. A representative magnification of an intracellular selected detail (white rectangle) of the indicated CDS
sample is shown displaying compartmentalization of the brighter DCF fluorescence signal. (B) Statistical analysis of the fluorescence intensity per cell as result-
ing from the averaged values+SEM of about 100 randomly selected different cells for each sample from at least in-duplicate experiments; statistical analysis of
the differences is also shown. (C) Correlation plot between the complex I activity normalized to the CS activity and the DCF-related fluorescence signal/cell for
individual and averaged fibroblast samples (see symbol legend, means+SEM).
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demonstrated that the sumoylation of RIP140 modulates its re-
pressive activity (41). The simultaneous upregulation of both
the Hsa21 genes, due to the primary dosage effect, might
exert a synergistic effect. Silencing and re-expression experi-
ments showed that RIP140 expression significantly affects
oxidative metabolism and mitochondrial biogenesis (42).
Even mild RIP140 overexpression repressed nuclear mito-
chondrial genes involved in all the respiratory chain com-
plexes (43). We previously demonstrated that the same
genes were repressed in DS foetal hearts (3).
Two other genes mapping to Hsa21, the kinase DYRK1A
and the regulator of calcineurin 1 (DSCR1/RCAN1), were
demonstrated to control PGC-1a via the Calcineurin/NFAT
pathway, largely through the binding of NFATc to the
PGC-1a promoter (44). The concurrent overexpression of
the Hsa21 genes RIP140, SUMO3, RCAN1 and DYRK1A
and the downregulation of NFATc genes (45), observed in
DS samples, is expected to result in the depression of
PGC-1a expression.
In this study, we have demonstrated that some mitochon-
drial alterations are more pronounced in fibroblasts derived
from DS foeti with heart defects. It must be pointed out that
not all the subjects with trisomy 21 develop congenital cardio-
pathies, even though a heart developmental delay has been
demonstrated in all DS human embryos at 8–10 gestational
weeks (46). This suggests that a different inter-individual
genetic background may affect the severity of the cardiopathic
outcome in DS patients by impairing the oxidative metabol-
ism. Assuming that altered cardiovascular development in
DS likely originates from the trisomy of a critical Hsa21
region between Tiam1 and Kcnj6 (47), a more severe
cardiac phenotype might be associated with different bioener-
getic phenotypes characterized, at the cellular level, by a
larger mitochondrial Ca2+ load and related ROS generation,
as observed in CDS-HFF. Interesting is the evidence that the
induction of oxidative stress in pregnant mice on day 7.5 dis-
rupts cardiac neural crest migration and causes outflow tract
defects like that observed in DS, and that antioxidant adminis-
tration before the induction prevents the heart defects (48).
Implications of our findings have a potential therapeutic
value, as a number of drugs are becoming available to specif-
ically inhibit the observed mitochondrial alterations. Some
protocols are being developed to improve oxidative imbalance
in DS using antioxidants such as the coenzyme Q10 (49,50).
On the basis of our results, we also plan to investigate the
effects of PPARg agonists and/or of PGC-1a activators. The
combination of these pharmacologically active compounds
might correct mitochondria-related dysfunctions in trisomic
foeti/patients.
MATERIALS AND METHODS
Ethics Statement
Human primary lines of HFF used in this study were obtained
from the ‘Telethon Bank of Fetal Biological Samples’ at the
University of Naples according to protocols approved by the
local Institutional Ethics Committee.
Samples
Skin biopsies were explanted from 13 human foeti after thera-
peutic abortion at 18–22 gestational weeks and were classified
as follows: five euploid human foeti (N-HFF) and eight foeti
with trisomy of Hsa21 (DS-HFF) including four foeti with
CHD, named CDS-HFF and four foeti without heart defects,
named NCDS-HFF (Supplementary Material, Table S1).
Fibroblasts from biopsies were cultured in T25 flasks (BD
Falcon) with Chang medium B+C (Irvine Scientific) supple-
mented with 1% penicillin/streptomycin (Gibco) at 378C in
5% CO2 atmosphere; all the analyses described throughout
this study were carried out at passages 4–5. Karyotype ana-
lysis was performed by standard G-banding technique.
The presence of CHD was established by colour Doppler
foetal echocardiography followed by direct examination at
the time of tissue explantation and dissection.
RNA extraction and quantitative real-time PCR
Total RNA from each sample was extracted using TRIzol
reagent (Gibco/BRL Life Technologies, Inc., Gaithersburg,
MD, USA) and was reverse-transcribed using the iScript
cDNA Synthesis kit (Bio-Rad Laboratories Inc., Hercules,
CA, USA). Real-time PCR was performed using iQ Supermix
SYBR Green 2X on a Bio-Rad iCycler according to the man-
ufacturer’s protocols. PCR reactions were performed in tripli-
cate. Primer pairs (MWG Biotech, Ebersberg, Germany) were
designed using the Primer 3 software (http://frodo.wi.mit.
edu/primer3) to obtain amplicons ranging from 100 to
150 bp (Supplementary Material, Table S2). GAPDH and
RPL13A housekeeping genes were chosen as reference genes.
Morphological analysis
Fibroblasts from trisomic and euploid foeti were fixed and em-
bedded for the electron microscope, using agarose as an inter-
mediate embedding medium (51). Cells were fixed in petri
dishes with 4% paraformaldehyde and 5% glutaraldehyde in
PBS buffer (0.1 M, pH 7.3) for 30 min at room temperature,
Figure 7. Effect of FCCP, DPI and db-cAMP on ROS production in DS fibro-
blasts. Cultured foetus-derived fibroblasts representative of euploid (BIO23)
and DS non-cardiopathic (BIO45) or cardiopathic (BIO22) samples were
treated for 2 h with either of 0.5 mM FCCP, 100 mM DPI or 100 mM
db-cAMP and then assessed by LSCM for ROS production by DCF. The
values shown are means+SEM (n ¼ 3 under each condition) of the
DCF-related fluorescence intensity/cell normalized for each fibroblast
sample to untreated cells. When statistically significant, the difference
between untreated and compound-treated cells is reported.
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then washed in buffer, scraped from culture plates and pelleted
by centrifugation for 10 min at 2000g; the supernatant was dis-
carded and the cells were resuspended in 1 ml of 2% liquid
agarose at 658C. Again, the reaction tube was centrifuged
for 5 min at 1000g to concentrate the cells in agarose. The
agarose-cell pellet was solidified in ice for 30 min, and then
the agarose cone was carefully taken out of the reaction tube
and divided into small pieces (1 mm3). The agarose-cell
blocks were post-fixed in osmium tetroxide (1% in PBS
buffer) for 1 h at 48C, dehydrated and transferred first to pro-
pylene oxide, then to a mixture of propylene oxide-Epon (1:1)
and finally embedded in Epon resin. The Epon blocks were
polymerized for 2 days at 608C and then sectioned with a
diamond knife to give thin sections, 70–80 nm each; the sec-
tions were picked up on 200 mesh copper grids, stained with
uranyl acetate (5% in 50% methanol) and Reynolds lead
citrate (52) and observed on a Philips 208S transmission elec-
tron microscope. Micrographs were acquired with a Mega
View II Soft Imaging System camera. Three N-HFF
(BIO-21, BIO-23, BIO-27) and six DS-HFF samples
(BIO24, BIO-36, BIO-37, BIO-44, BIO-48 and BIO55) were
analysed using the ‘fractionator’ method to obtain a systematic
and uniformly random sampling, which ensures that even for
relatively small samples, the error is so small that it may
safely be ignored (53). Fifty cells per sample were analysed
and for each cell the percentages of inner and outer membrane
Figure 8. Confocal microscopy analysis of mitochondrial Ca2+ in DS live fibroblasts. (A) Representative LSCM imaging of the Rhod-1-related fluorescence of
euploid (N-HFF) and DS (NCDS-HFF and CDS-HFF) fibroblasts. A representative magnification (white rectangle) of the indicated CDS sample is shown dis-
playing the punctuate compartmentalization of the Rhod-1-fluorescence signal. (B) Statistical analysis of the fluorescence intensity per cell as resulting from the
averaged values+SEM of about 100 randomly selected different cells for each sample from at least in-duplicate experiments; when statistically significant, the
difference when compared with the euploid samples is shown. (C) Correlation plot between the Rhod-1- and DCF-related fluorescence signal/cell for averaged
fibroblast samples (see symbol legend, means+SEM).
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breakages, branched mitochondria and mitochondria with
concentric or longitudinal cristae were determined. Further-
more, for each sample, 25 micrographs were collected to
evaluate the mitochondrial volume density (Vmt, relative
volume of mitochondria on cell volume) and mitochondrial
cristae volume density (Vmc, relative volume of mitochon-
drial cristae on mitochondria volume) (54). The volume
density (also named relative volume or volume fraction) is a
ratio between volumes. This is an intuitive parameter, unbia-
sedly estimated by overlaying a test system of points on
images and then counting those falling over the objects of
interest and those over the reference space. The ratio of
points gives the estimation of volume. According to Delesse’s
principle, the volume fraction of an object varies proportional-
ly to their area fraction as measured in random 2D
sections; this means that each point controls an area in a 2D
section and is related to a defined volume in the 3D organ (55).
Western blot analysis
Cells were washed twice with ice-cold PBS and lysed in RIPA
buffer (NaCl 154 mM; Deoxicolic Acid 12 mM; NaF 0.95 mM;
Figure 9. Effect of ruthenium red on ROS production and respiratory activity in DS live fibroblasts. Cultured foetus-derived fibroblasts representative of euploid
(BIO23) and DS non-cardiopathic (BIO45) or cardiopathic (BIO22) samples were treated with 10 mM ruthenium red (RR) for 4 h and then assessed by LSCM for
ROS production and mtCa2+ by DCF and Rhod-1, respectively. (A) DCF-related fluorescence imaging of untreated and RR-treated fibroblasts (representative of
three different experiments). (B) Statistical analysis of the DCF-related (upper histogram) and Rhod-1-related (lower histogram) fluorescence intensity per cell.
The average values+SEM of about 100 randomly selected different cells for each sample from three different experiments are shown. (C) Effect of RR on the
respiratory activity of the same representative samples of N-, NCDS- and CDS-HFF as in (A). The OCRRR was measured as described in the legend of Figure 3
and treatment with RR as in (A); the bars are means+SEM of the average determinations for each sample (untreated and RR-treated) carried out in triplicate.
When statistically significant, the difference between untreated and RR-treated cells is reported in (B) and (C).
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Triton X-100 1%; SDS 2%; PMSF 2 mM) in phosphate buffer
in the presence of protease inhibitors. The protein concentra-
tion was determined using the Bio-Rad protein assay
(Bio-Rad Laboratories Inc.). For western blot analysis, total
lysates were boiled for 5 min in Laemmli sample buffer and
analysed on 7.5% SDS–PAGE. Gels were then blotted onto
nitrocellulose transfer membranes (Schleicher and Shuell
GmbH, Dassel, Germany) using a Bio-Rad apparatus. After
transfer, the filters were blocked at room temperature for 1 h
with 5% BSA in TTBS (150 mM NaCl, 20 mM Tris-HCl pH
7.5). After washing twice with TTBS (150 mM NaCl, 20 mM
Tris-HCl pH 7.5, 0.1% Tween 20), filters were incubated over-
night at 48C with rabbit polyclonal primary antibody to
PGC-1a (1:1000, Abcam, Cambridge Science Park, Cam-
bridge, UK). The filters were washed extensively with TTBS
and incubated for 1 h at room temperature with anti-rabbit
peroxidase-conjugated secondary antibody (Amersham, Little
Chalfont, Buckinghamshire, UK) diluted 1:1000 in TTBS.
The filters were then washed six times with TTBS and once
with TBS and developed using an ECL western blotting sub-
strate detection method (Pierce, Rockford, IL, USA). For
reprobing, the nitrocellulose filters were re-hydrated and
Figure 10. Analysis of the mitochondrial DNA content and expression of PGC-1a in DS fibroblasts. (A) Absolute qRT-PCR analysis of mtDNA (see Materials
and Methods for details). The bars are means+SEM from five euploid and eight DS fibroblast samples; a distinction between non-cardiopathic (NCDS, n ¼ 4)
and cardiopathic (CDS, n ¼ 4) foetus-derived fibroblasts is also reported. (B) Expression analysis of the PGC-1a by qRT-PCR. The values, means+SEM, of the
DS samples are normalized to that of the euploid fibroblasts. (C) Analysis of the PGC-1a protein. (Panel on the left) Western blotting of PGC-1a on total cellular
protein extracts from euploid and DS samples (representative of two to three different analyses carried out for each sample). (Panel on the right) Densitometric
analysis of the PGC-1a-related immunodetected bands (means+SEM of two to three assays). To compare different electrophoretic runs, the densitometric value
(normalized to tubulin) of the euploid sample BIO-23 was taken as an internal reference. When statistically significant, the P-value, when compared with the
euploid samples, is shown in (A and B) and (C and D) Correlation plot between the normalized PGC-1a protein expression and the mt-DNA copy number for
averaged fibroblast samples (see symbol legend, means+SEM).
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stripped for 30 min at 378C in restore western blotting strip-
ping buffer (Pierce) and washed extensively with TTBS.
Results were standardized to alpha tubulin and analysed
using NIH Image J (Rasband, W.S., ImageJ, U. S. National
Institutes of Health, Bethesda, Maryland, USA, http://imagej.
nih.gov/ij/, 1997–2012).
Measurement of the respiratory activity in intact cells
Cultured cells were gently detached from the dish by tripsiniza-
tion, washed in PBS, harvested by centrifugation at 500g
for 5 min and immediately assessed for O2 consumption with
a high-resolution oxymeter (Oxygraph-2k, Oroboros Instru-
ments). About 1 × 106 viable cells per ml were assayed in
50 mM KPi, 10 mM Hepes, 1 mM EDTA, pH 7.4 at 378C;
after attainment of a stationary endogenous substrate-sustained
resting oxygen consumption rate (OCRRR), 2 mg/ml of
the ATP-synthase inhibitor oligomycin was added (OCROL)
followed by addition of 0.5 mM of the uncoupler carbonilcya-
nide p-triflouromethoxyphenylhydrazone (FCCP) (OCRUNC).
The rates of oxygen consumption were corrected for 2 mM
KCN-insensitive respiration. The RCR was obtained by the
ratio OCRUNC/OCROL, the leak by the ratio OCROL/OCRUNC
and the ATP-synthesis-linked respiration (OXPHOS) by the
ratio (OCRRR-OCROL)/OCRUNC (56).
Measurement of the activity of mitochondrial respiratory
chain complexes
The specific activities of NADH:ubiquinone oxidoreductase
(complex I), ubiquinone:cytochrome c oxidoreductase
(complex III) and cytochrome c oxidase (complex IV) were
assayed spectrophotometrically on frozen-thawn and
ultrasound-treated cells in 10 mM Tris, 1 mg/ml serum
albumin, pH 8.0. Complex I was assayed (in the presence of
1 mg/ml of antymicin A plus 2 mM KCN) by following the
initial 2 mg/ml rotenone-sensitive rate of 50 mM NADH oxida-
tion (1340nm ¼ 6.22 mM21 cm21) in the presence of 200 mM
decylubiquinone (dUQ) as electron acceptor; complex III
was assayed (in the presence of rotenone plus KCN) by fol-
lowing the initial 1 mg/ml antymicin A-sensitive rate of
50 mM ferri-cytochrome c reduction (1550nm ¼ 21.1 mM21
cm21) in the presence of 200 mM dUQH2 as electron donor.
Complex IV was assayed by following (in the presence of
antymicin A) the initial 2 mM KCN-sensitive rate of 20 mM
ferro-cytochrome c oxidation under aerobic conditions. The
activities were normalized to the initial cell number and to cel-
lular protein content (57). Citrate synthase catalyses the reac-
tion between acetyl coenzyme A and oxaloacetic acid to form
citric acid. Citrate synthase activity was assayed spectrophoto-
metrically (1412nm ¼ 13.6 mM21 cm21) measuring the reaction
between CoA-SH and DTNB (5,5′-dithiobis (2-nitrobenzoic
acid)) to form 5-thio-2-nitrobenzoic acid (TNB) (58).
Laser scanning confocal microscopy (LSCM) live
cell imaging of mitochondrial membrane potential,
ROS and mtCa21
Cells cultured at low density on fibronectin-coated 35-mm
glass-bottom dishes were incubated for 20 min at 378C with
the either of the following probes: 2 mM tetramethylrhodamine
ethyl ester (TMRE) to monitor mitochondrial membrane po-
tential (DCm); 10 mM 2,7-dichlorofluorescin diacetate, which
is converted to dichlorofluorescein by intracellular esterases,
for detection of H2O2; 5 mM X-Rhod-1 AM for mitochondrial
Ca2+. All probes were from Molecular Probes (Eugene, OR).
Stained cells were washed with PBS and examined with
a Nikon TE 2000 microscope [images collected using a ×60
objective (1.4 NA)] coupled to a Radiance 2100 dual-laser
LSCM system (Bio-Rad). TMRE and Rhod-1 red fluorescence
were elicited by exciting with the He–Ne laser beam (lex
543 nm), whereas dichlorofluorescein green fluorescence was
elicited with the Ar–Kr laser beam (lex 488 nm). Acquisition,
storage and analysis of data were performed with LaserSharp
and LaserPix software from Bio-Rad or ImageJ version 1.37.
Superimposed confocal planes were analysed by means of
the ‘stack’ function of the LCS-Analysis Tools, which
produced an xz intensity profile of the average value of
the pixels within marked edges, including a single cell, as a
function of each focal plane. The integrated value of the xz
profile was taken as a measure of the fluorescence intensity
of that individual cell relative to the selected emission
channel. Correction was made for the minimal background
by repeating the procedure in a cell-free field. About 100
single cells were analysed for each imaging analysis (57).
Statistics
The ANOVA test with Bonferroni post hoc correction was
applied to evaluate the statistical significance of differences
measured throughout the data sets presented. Concerning
stereological investigations, the data obtained from each
sample were averaged per group (N-HFF, DS-HFF,
NCDS-HFF and CDS-HFF) and statistical evaluations were
performed by using two nonparametric statistical tests, the
Kolmogorov–Smirnov and the Kruskal–Wallis tests. The
threshold for statistical significance (P-value) was set to 0.05.
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SUPPLEMENTARY MATERIALS 
 
Table S1 
Characteristics of the primary lines of foetal fibroblasts obtained from foetuses after 
therapeutic abortion at 18-22 gestational weeks. 
 
 NAME KARYOTYPE HEART DEFECT 
BIO-21 46,XY NO 
BIO-23 46,XX NO 
BIO-27 46,XX NO 
BIO-29 46,XY NO 
N-HFF 
BIO-30 46,XY NO 
BIO-24 47,XY,+21 NO 
BIO-37 47,XY,+21 NO 
BIO-45 47,XX,+21 NO NCDS-HFF 
BIO-48 47,XY,+21 NO 
BIO-22 47,XX,+21 TOF 
BIO-36 47,XX,+21 TOF 
BIO-44 47,XX,+21 AVC 
DS-HFF 
CDS-HFF 
BIO-55 47,XX,+21 AVC 
 
N-HFF = fibroblasts from euploid human foeti; DS-HFF = fibroblasts from foeti with trisomy of 
Hsa21; CDS-HFF = fibroblasts from foeti with congenital heart defects; NCDS-HFF = fibroblasts 
from foeti without heart defects.  
Heart defects: TOF= Tetralogy of Fallot; AVC= Atrio-Ventricular Canal defect. 
TABLE S2. Genes analyzed in this study by qRT-PCR. 
 
GENE 
NAME PRIMER SEQUENCES 
BTG3 LEFT: GAGGCAGTTGAGAGGTTTGC RIGHT: GAGTGAGCTCCTTTGGCAAG 
ITSN1 LEFT: GTGAGCGGCACTGATTTGT RIGHT: GATCATGCTTCGCTCTTTCC 
DYRK1A LEFT: GATATCATATGGGTCAGGTCATTTT RIGHT:CTGGACTGTAACATAACACAGTATGC 
SOD1 LEFT: GCATCATCAATTTCGAGCAG  RIGHT: CAGCCTCTGTATTATCTCCAA  
NRF1 LEFT: AAACGGAAACGGCCTCAT RIGHT: CTTGCTGTCCCACACGAGTA  
IMMT LEFT: AGTTTGTCCTCCGTCCATTG RIGHT: CCACCAATACCTCCACCAAC  
PGC1A LEFT: ACAGAACTGAGGGACCGTTTT RIGHT: TTTCAAGAGCAGCAAAAGCA  
NRF2 LEFT: CCTGAACTGGTTGCACAGAA  RIGHT: ACAAATCATGTCCCCATCGT  
RIP140 LEFT: TGCCGTTGACAAAAAGTCTG  RIGHT: CTTTGACAGGTGGGAAATGC  
NDUFA1 LEFT: CTGGCTACTGCGTACATCCA  RIGHT: TGCGCCTATCTCTTTCCATC  
NDUFA8 LEFT: GTCATGCCGGGGATAGTG  RIGHT:TTAAGCACAGCAGAACTAATTTTCA  
NDUFB8 LEFT:  GCCAAGAAGTATAATATGCGTGTG  RIGHT: GTCAGGGAGCTTCGGGTAG  
NDUFS2 LEFT: GAATGGGCACAGGAGTTTG  RIGHT: GGCCCAAAGTTCAGGGTAAT  
NDUFS6 LEFT: AGAAGGTCACGCACACTGG  RIGHT: CACGGGCTGCTCTGCTAT  
RCAN1 LEFT: TTTGCTCAGACCTTACACATAGGA  RIGHT: GGGAGGGGAGATCAGAAACT 
NFATC2 LEFT: GAGTTCACATCCCAGAGTCCA  RIGHT: GAGCACTCGATGGGGTTAGA 
NFATC3 LEFT: CTTTGCAATGGCAAGAGGA  RIGHT: GATGAGGCACAGGCAAAGAT 
NFATC4 LEFT: GTGAGATCATTGGCCGAGAC RIGHT: CCAGGTGATGACAGTTCACG 
GAPDH LEFT: TGCACCACCAACTGCTTAGC RIGHT: GGCATGGACTGTGGTCATGAG 
RPL13A LEFT: CCTGGAGGAGAAGAGGAAAGAGA RIGHT: TTGAGGACCTCTGTGTATTTGTCA 
Left and Right primer sequences, obtained from Primer 3 software, are indicated for each analyzed 
gene. 
 
Figure S1. Intramitochondrial calcium measurements in DS-HFF samples with aequorin. 
 
 
 
 
 
Starting from a calibration curve, we measured the mtCa2+ concentration in three samples per group 
on 15 coverslips for each sample. We found a significative 40% calcium overload in DS-HFF 
samples, irrespective of whether they were derived from cardiopathic trisomic foeti, when 
compared to the control group (p<0.01). Results are shown as mean of the determinations in each 
group ± standard error. N-HFF = Euploid fibroblasts, DS-HFF = Hsa21 trisomic fibroblasts, NCDS-
HFF = Hsa21 trisomic fibroblasts from DS foeti without heart defects, CDS-HFF = Hsa21 trisomic 
fibroblasts from DS foeti with heart defects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table S3. Mitochondrial genes downregulated in DS heart tissues with NRF1 binding site in 
their promoter regions. 
 
Gene name Score Promoter region position 
Binding site 
sequence 
ECGF1 1,00 -13 CGCATGCGCA 
SCO2 1,00 -14 CGCATGCGCA 
PIN4 0,98 -282 CGCGTGCGCA 
IDH3A 0,97 -24 CGCTTGCGCA 
UQCRC1 0,96 7 CGCTTGCGCG 
NDUFB8 0,96 -9 CACATGCGCA 
RPL10 0,96 -12 CACATGCGCA 
ENDOG 0,91 -161 CGCCTGCGCA 
FPGT-TNNI3K 0,91 23 CGCATGCGCC 
SDHA 0,91 -88 CGCCTGCGCA 
UQCRC2 0,91 -264 CGCATGCGCC 
ETFB 0,90 -9 CGCCTGCGCG 
GLUD1 0,90 -31 CGCCTGCGCG 
NDUFAB1 0,90 -43 CGCCTGCGCG 
CYCS 0,90 -208 CGCAAGCGCA 
SDHB 0,90 -65 CGCATGCCCA 
HSPA9 0,89 -171 CGCATGTGCG 
MRPL15 0,88 -52 CGCGCGCGCA 
SLC25A12 0,88 -63 CGCGTGCGGA 
VDAC1 0,88 -59 TGCGTGCGCA 
HCCS 0,88 -25 CGCGTGCCCG 
IDH3B 0,87 -166 TGCTTGCGCA 
IDH2 0,86 -262 CGCTTGCGAG 
COX4NB 0,84 -292 CACGTCCGCA 
COQ7 0,81 -363 CGCCCGCGCA 
ETFA 0,81 -71 CGCCTGCCCA 
GOT1 0,81 -395 CGCCCGCGCA 
NDUFA13 0,81 -265 GGCCTGCGCA 
NDUFS2 0,81 -78 CGCCTGCGTA 
PDHA1 0,81 -165 CGCAGGCGCT 
DLAT 0,80 33 AGCCTGCGCG 
GCSH 0,80 -18 CGCCTCCGCG 
MOSC2 0,80 -6 AGCCTGCGCG 
AK2 0,80 -303 CCCACGCGCA 
 
 
NRF1 target genes are sorted with a cut-off affinity score = 0.80.  
 
 
 
 
 
 
 
 
 
 
 
Table S4. Mitochondrial genes downregulated in DS heart tissues with ERRa binding site in 
their promoter regions. 
 
Gene name Score Promoter region position 
Binding site  
sequence 
HSPA9 0,95 -66 GACTCAAGGTCACA 
MOSC2 0,94 -174 CGCTGAAGGTCATG 
SDHA 0,93 -390 TTGTGGAGGTCACA 
TXN2 0,92 -298 ATCACGAGGTCAAA 
MRPL35 0,92 -231 ATCACAAGGTCAGG 
BDH1 0,91 -193 GGATCAAGGACAGA 
NDUFB8 0,90 -208 AGAAAAAGGACACA 
COX7A2 0,90 -48 TCGAAAAGGTCAGG 
SDHB 0,90 -446 ATCACGAGGTCAGG 
DLAT 0,89 -428 AACTGAAGGTGACA 
NDUFAB1 0,88 -417 AAAAAAAGGACAAA 
COQ7 0,88 -108 TCGAAGAGGTCACG 
MRPS12 0,88 23 ACCTAAAGGTGAGG 
TIMM23 0,87 -6 CCCGGAAGGTCAGC 
ETFA 0,87 -296 ACCCCGAGGTCAGC 
ATP5B 0,87 -289 TGATCTAGGTGACA 
IDH3B 0,86 -153 GTGGGGAGGTCATG 
ECI1 0,86 -292 AGCTCGCGGTCACG 
MRPL15 0,85 -112 ACTAAAAGGACAAC 
ETFB 0,85 -449 ACATGGAGGTGAAG 
COX4NB 0,85 -94 GCACGGAGGTCACC 
CYCS 0,84 -367 ACCTAGAGGTCTCC 
TNNI3K 0,84 -329 TTTTCAAGATCATT 
UQCRFS1 0,84 -236 ATCTCTAGGTCTTC 
SLC25A4 0,83 -205 GTTTAAAGGGCACA 
GOT1 0,83 -405 TGGTCAAGGTCGCC 
PIN4 0,83 -99 TCTTATTGGTCAGA 
SCO2 0,81 -258 CCATGGCGGTCAGC 
NFS1 0,81 -92 CGAGCGAGGTGAGG 
CKMT2 0,81 -437 GGAAGGAGGTCCCT 
IMMT 0,80 -41 ATATCCAGCTCATA 
DLST 0,80 -191 TCCTGAAGGTGTAT 
MIPEP 0,80 -265 GCCTGAAGGAGAAG 
COX10 0,80 -14 GCCTGAAGGACTTC 
 
ERRa target genes are sorted with a cut-off affinity score = 0.80. A possible target of ERRa is IMMT (in red), 
a gene involved in mitochondrial cristae pattern organization. 
 
 
 
 
 
 
 
Text S1 
 
Supplemental Methods 
 
Mitochondrial calcium measurement using aequorin 
Aequorin is a 21-kDa protein from various Aequorea species [1] which, in the active form, consists 
of an apoprotein and a covalently bound prosthetic group (coelenterazine). When Ca2+ ions bind to 
three high-affinity sites (EF-hand type), aequorin undergoes an irreversible reaction in which a 
photon is emitted.  
Mitochondrial Calcium was measured by the method described by [2]. Cells were cultured on 13 
mm-diameter coverslips in Chang medium B+C (Irvine scientific) at 37 °C and 5% CO2 for 24 h 
and then infected with an adenoviral vector containing the plasmid with the cDNA coding for a 
mitochondrial-matrix addressed mutant form of aequorin. This construct includes the 
mitochondrial-targeting presequence of subunit VIII of human cytochrome c oxidase fused to the 
aequorin cDNA. Forty-eight hours after transfection, the cells were incubated for 1.5 h with 5 µM 
coelenterazine in Chang medium in a 5% CO2 atmosphere. Coverslips with the transfected cells was 
placed in a saline solution-perfused chamber at 37 °C, and the number of emitted photons per 
second was measured after the stimulation with histamine using a photomultiplier with amplifier-
discriminator. The output of the amplifier-discriminator was captured by a photon-counting board 
in a microcomputer and stored for further analysis. In order to calibrate the row luminescent signal 
in terms of [Ca2+] an algorithm has been developed that takes into account the instant rate of photon 
emission and the total number of photons that can be emitted by the aequorin of the sample. To 
obtain the latter parameter, at the end of each experiment the cells were lysed by a hyposmotic 
medium containing 10 mM CaCl2 and 0,1% Triton X-100 in order to discharge all the aequorin that 
was not consumed during the experiment. 
 
 
1. Shimomura O (1986) Isolation and properties of various molecular forms of aequorin. The 
Biochemical journal 234: 271-277. 
2. Pinton P, Rimessi A, Romagnoli A, Prandini A, Rizzuto R (2007) Biosensors for the detection of 
calcium and pH. Methods in cell biology 80: 297-325. 
 
 
Text S2 
 
Supplemental Methods 
 
Bionformatic binding analysis  
The promoter regions from -450bp to +50bp of mitochondrial genes downregulated in DS heart tissues were 
analyzed in order to recognize DNA binding motifs for both NRF1 and ERRα matrices (from PSCAN 
software http://159.149.109.9/pscan/). The list of downregulated genes was ranked according to the 
prediction of binding affinity of their promoter regions to NRF1 and ERRα binding sites with a cut-off 
affinity score = 0.80 and p-value<0.003. 
 
 
